Michigan Technological University

Digital Commons @ Michigan Tech
Dissertations, Master's Theses and Master's Reports
2016

Effect of disulfide bond scrambling on protein stability,
aggregation, and cytotoxicity
Colina Dutta
Michigan Technological University, ctdutta@mtu.edu

Copyright 2016 Colina Dutta
Recommended Citation
Dutta, Colina, "Effect of disulfide bond scrambling on protein stability, aggregation, and cytotoxicity", Open
Access Dissertation, Michigan Technological University, 2016.
https://doi.org/10.37099/mtu.dc.etdr/129

Follow this and additional works at: https://digitalcommons.mtu.edu/etdr
Part of the Biochemistry, Biophysics, and Structural Biology Commons, and the Chemistry Commons

EFFECT OF DISULFIDE BOND SCRAMBLING ON PROTEIN STABILITY,
AGGREGATION, AND CYTOTOXICITY

By
Colina Dutta

A DISSERTATION
Submitted in partial fulfillment of the requirements for the degree of
DOCTOR OF PHILOSOPHY
In Chemistry
MICHIGAN TECHNOLOGICAL UNIVERSITY
2016
©2016 Colina Dutta

This dissertation has been approved in partial fulfillment of the requirements for the
Degree of DOCTOR OF PHILOSOPHY in Chemistry.

Department of Chemistry
Dissertation Advisor:

Dr. Ashutosh Tiwari

Committee Member:

Dr. Haiying Liu

Committee Member:

Dr. Lanrong Bi

Committee Member:

Dr. Chandrashekhar Joshi

Department Chair:

Dr. Cary Chabalowski

This dissertation is dedicated to
“My Mother

Table of Contents
Preface........................................................................................................................ viii
Acknowledgements ...................................................................................................... ix
Abstract ........................................................................................................................ xi
Chapter 1. Introduction ................................................................................................. 1
1.1 Proteins ................................................................................................................ 1
1.2 Structure of Proteins ............................................................................................ 2
1.3 The Protein Folding Problem .............................................................................. 5
1.3.1 Energetics of Protein Folding ...................................................................... 6
1.3.2 The Misfolded Scenario ................................................................................ 9
1.4 Protein Aggregation .......................................................................................... 11
1.4.1 Types of Aggregates.................................................................................... 13
1.4.2 Protein Aggregation and Neurodegenerative Diseases ............................. 15
1.5 The Model Proteins ........................................................................................... 19
1.5.1 Human Insulin ............................................................................................ 20
1.5.2 Lysozyme ..................................................................................................... 22
1.5.3 Serum Albumin ........................................................................................... 23
1.6 Aims of Research .............................................................................................. 25
References ............................................................................................................... 28
iv

Chapter 2. Methods ..................................................................................................... 33
2.1 Spectroscopy ..................................................................................................... 33
2.1.1 Ultraviolet (UV)-Visible Spectroscopy ....................................................... 34
2.1.2 Fluorescence Spectroscopy ........................................................................ 37
2.1.3 Fourier-Transform Infrared Spectroscopy ................................................. 45
2.2 Microscopy ........................................................................................................ 49
2.2.1 Scanning Electron Microscopy ................................................................... 49
2.2.2 Atomic Force Microscopy .......................................................................... 54
2.3 Cell Based Assays ............................................................................................. 56
2.4 Polyacrylamide Gel Electrophoresis ................................................................. 58
2.5 Mass Assisted Laser Desorption/Ionization (Time-of-Flight) Mass
Spectrometry ........................................................................................................... 62
References ............................................................................................................... 65
Chapter 3. Preformed Seeds Modulate Native Insulin Aggregation Kinetics ........... 68
Abstract ................................................................................................................... 68
Introduction ............................................................................................................. 70
Materials and Methods ............................................................................................ 74
Results ..................................................................................................................... 78
Discussion ............................................................................................................. 111
v

Conclusion............................................................................................................. 121
References ............................................................................................................. 122
Chapter 4. Disulfide Bond Scrambling at Acidic pH Promotes Insulin Aggregate
Toxicity ..................................................................................................................... 132
Abstract ................................................................................................................. 133
Introduction ........................................................................................................... 134
Materials and Methods .......................................................................................... 138
Results & Discussion ............................................................................................ 153
Conclusion............................................................................................................. 164
References ............................................................................................................. 165
Chapter 5. Protein aggregation in a crowded environment....................................... 173
Abstract ................................................................................................................. 174
Introduction ........................................................................................................... 175
Materials and Methods .......................................................................................... 177
Results & Discussion ............................................................................................ 180
Conclusion............................................................................................................. 189
References ............................................................................................................. 190
Chapter 6. Conclusion and Future Directions ........................................................... 193
Appendix ................................................................................................................... 196
vi

Permission for Figures 1.1, 1.2 and 2.12............................................................... 196
Permission for Figure 1.3 ...................................................................................... 197
Permission for Figure 1.4 ...................................................................................... 198
Permission for Figure 1.5 ...................................................................................... 199
Permission for Chapter 3 ....................................................................................... 200

vii

Preface
Contents of Chapter 1, 2, and 6 are written by the author of this dissertation. Chapters
3, 4 and 5 are edited and organized by the author based on previously published paper
(Chapter 3) and a manuscript in preparation (Chapter 5), details of which are described
below.
Chapter 3 is based on a five-author article that was published in The Journal of Physical
Chemistry 2015, 119:15089-99. The author of this dissertation performed majority of
the experiments, analyzed the data and wrote the paper. Ms. Mu Yang performed the
ANS and Bis-ANS fluorescence experiments and Dr. Fei Long and Dr. Reza
Shahbazian-Yassar helped with AFM imaging and analysis, respectively. Dr. Ashutosh
Tiwari is the corresponding author and he revised the manuscript.
Chapter 4 is based on a two-author article that is ready to be submitted in Chemical
Sciences (RSC Publications). The author of this dissertation performed all of the
experiments, analyzed the data and wrote the paper. Dr. Ashutosh Tiwari will be the
corresponding author and will revise the manuscript.
Chapter 5 is a three-author article for which the manuscript is under preparation. The
author of this dissertation performed majority of the experiments, analyzed all the data
and wrote the paper. Ms. Rashmi Adhikari performed the electrophoresis experiments.
Dr. Ashutosh Tiwari will be the corresponding author and will revise the manuscript.

viii

Acknowledgements
Pursuing doctoral study is a task that can never be possible without the help and support
of so many people who have touched my life in their own ways. I am indebted to all!
First and foremost, I would like to express my sincere gratitude towards my advisor
Dr. Ashutosh Tiwari for his continuous support, inspiration, and motivation for my
Ph.D. study and related research. His unflinching guidance and impeccable patience
succored me all the way through writing my dissertation.
Besides my advisor, I am thankful to the rest of my committee members: Dr. Haiying
Liu, Dr. Lanrong Bi and Dr. Chandrashekhar Joshi for their precious time, insightful
comments and encouragement.
I also owe my deepest gratitude towards Dr. Ravindra Pandey, without whom my Ph.D.
journey would not have been possible. I am also thankful to Dr. Ranjit Pati for his
encouragement, suggestions and support both on personal and professional front.
I would like to convey my sincere thanks to our former and current Department Chair
Dr.Sarah Green and Dr. Cary Chabalowski, respectively. I am also grateful to the
Department of Chemistry for the continuous funding support that made my journey
easier and less stressful. Million thanks to Celine Grace, Denise Laux, Charlene Page
and Margaret Dunsten for their assistance with a smile!
I would also like to thank my colleagues Dr. Jagadeesh Janjanam, Nethaniah Dorh, Mu
Yang and Rashmi Adhikari for all the scientific and non-scientific discussions and for
being there. Special thanks to Nethaniah for being extremely supportive during
ix

desperate times. I can’t thank Jagadeesh enough for patiently teaching me everything I
wanted to learn. He has been a continuous support as a postdoctoral researcher and a
friend in the Tiwari Lab and even after that.
Teaching has been an integral part of my graduate studies. I would like to thank my
teaching supervisors Sarah Hill, Laleh Vahdat, Aparna Pandey, Kelley Smith, and
Lorry Reilly, who taught me the ‘art of teaching’.
I would also like to thank some very special friends (Neil (Rahul) Bose, Noopur
Sharma, and Yogita Uplane) for their unique contributions towards my journey.
I am deeply indebted to my parents and my in-laws for their love and faith in me.
Last, but not the least, I owe everything to my husband Partha, without whom I could
not have reached here. His immense faith, sacrifice, dedication and encouragement
towards me, helped me sail through my doctoral studies.

x

Abstract
Proteins are nano-machines that carry out majority of the cellular functions.
Thermodynamically they are functional and stable within a very narrow range (1
kcal/mol). External perturbations in the form of pH change, thermal, or
oxidative/reducing stress can destabilize the protein resulting in misfolding and
aggregation. Prolonged environmental stress can affect the cells adaptive response
resulting in loss of ability to refold or recycle proteins. This can lead to accumulation
of misfolded or aggregated proteins within the cell. Such accumulation of aggregated
proteins have been associated with neurodegenerative disorders such as Amyotrophic
Lateral Sclerosis (ALS), Parkinson’s, Huntington’s, and Alzheimer’s disease. There is
a general consensus among scientists that aggregated proteins cause disease by a ‘toxic
gain of function’. However, there is a huge debate among scientists on what are the
toxic forms of protein aggregates. This is largely due to lack of research that have
looked at the relationship between morphology of aggregates and their toxicity.
Therefore, such studies that can help clarify the relationship between morphologically
different forms of aggregates and their associated toxicity are needed.
In this dissertation, we study how disulfide reducing environment can impact protein
stability, aggregation, and cytotoxicity. We also study effect of molecular crowding
agent polyethylene glycol (PEG) (600 and 2000 g/mol) on providing protection against
reducing and thermal stress. Disulfide bonds are covalent interactions that provide
major stability to the protein in conjunction with several non-covalent interactions such
as hydrophobic interactions, hydrogen bonding, Van der Waal and electrostatic
xi

interactions. These interactions help the proteins to fold into its native threedimensional fold. However, the cytoplasmic environment in cells is highly reducing
and can compromise the disulfide bonds leading to protein aggregation. To better
understand how disulfide bond scrambling can affect protein aggregation, we used
insulin as a model protein. We made seeds of insulin by incubating the protein in
presence of disulfide reducing agent for varying lengths of time at 37 °C. These seeds
were labeled as ‘nascent’, ‘intermediate’, or ‘mature’ based on their ability to induce
and promote aggregation of native protein with different kinetics. Nascent seeds
promoted fastest insulin aggregation and formed amorphous aggregates. In another
related study we used a combination of pH (acidic to basic) and temperature (37 and
65 °C) to generate morphologically different types of insulin aggregates under disulfide
reducing/non-reducing conditions. These aggregates were characterized by different
techniques and tested for their toxicity on SH-SY5Y cells. Cytotoxicity studies of
insulin aggregates on neuroblastoma cells showed that aggregates formed from
disulfide reduced proteins at acidic pH were more toxic compared to the aggregates
formed at neutral or basic pH. Lastly, we wanted to study how these properties could
be impacted by molecular crowding. We mimicked the intracellular crowded milieu in
vitro by using PEG to investigate the effect of crowding on lysozyme stability and
aggregation under thermal and reducing stress. We observed that PEG-2000 stabilized
the molten globule intermediate of lysozyme in the presence of a non-thiol based
reducing agent. Overall, the results indicates an intricate relationship of pH,
temperature, and reducing environment impacting proteins aggregation and its
associated toxicity.
xii

Chapter 1. Introduction
1.1 Proteins
Proteins form the center of any biological process. They essentially are the building
blocks of life that are composed mainly of 20 standard amino acids. The sequence of
amino acid in a protein, encodes for its function; that in turn dictates its interaction
with other biological molecules. The function of proteins range from maintaining cell
shape (structural proteins) to catalyzing biochemical reactions within the cell
(enzymes). Proteins also function as hormones that act as chemical messengers and
direct processes within the living system.
The amino acids within a protein, are covalently bonded together by the peptide
bonds between the alpha carbon (Cα) atoms of amino (N-terminal) and carboxyl (Cterminal) groups of adjacent amino acids. Linkage between amino acids occurs by a
condensation reaction in which a water molecule is expelled leading to the formation
of the peptide bond. Studies by Pauling and Corey revealed that the alpha carbon
atoms in the peptide bond are separated by three covalent bonds Cα-C-N-Cα. X-ray
diffraction studies revealed that the C-N bond in a co-planar peptide bond is slightly
shorter than that present in an amine. This suggests the presence of a partial negative
charge on oxygen and a positive charge on nitrogen. All these observations lead to
the conclusion that the C-N bond within a peptide bond is rigid and free rotation is
restricted due to partial double bond character. However, free rotation is possible
around N-Cα and C-Cα bonds. The rigidity of the peptide bond in a protein provides
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the structural basis in proteins and defines the secondary structure and tertiary fold in
the protein.

1.2 Structure of Proteins
The primary structure of a protein is formed by its amino acid sequence. Amino acids
have a positively charged amino group and a negatively charged carboxyl group
around neutral pH. They differ by the alkyl (R) group that can be broadly divided into
hydrophobic and hydrophilic. Uncharged as well as aromatic alkyl groups are
hydrophobic whereas charged ones are hydrophilic in nature. The folding of a protein
is determined by the amino acid sequence since the hydrophobic residues form the
core of the protein while the charged hydrophilic residues interact with the solvent in
the cellular milieu. This ‘preference’ of interaction requires the protein backbone
(peptide bond) to fold into the hydrophobic core, although it is highly polar and
hydrophilic. This leads to the formation of secondary structures: α-helix and β-sheet
that help in exposing the peptide bond to the solvent while the hydrophobic amino
acids form the core of the folded protein.
The α-helix is a common element of secondary structure in proteins and is
predominantly right-handed (Figure 1.1). The helical structure forms in a way such
that the N-H group of the nth residue of the protein is hydrogen bonded to the C=O
group of the (n-4) residue. This ensures tight packing and Van der Waal contact
throughout the helix. The alkyl groups point outward from the helix to minimize steric
effects.
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Figure 1.1 Right handed helix with the planes of the peptide bond parallel along the
long axis of helix (shown as the rod)1. From: Lehninger Principles of Biochemistry 6E,
by David L. Nelson and Michael M. Cox, Copyright 2013, by W.H. Freeman and
Company. Used by permission of the publisher.
Another element of the secondary structure in protein is the β-sheet (Figure 1.2). The
protein backbone is fully extended in this pleated structure and hydrogen bonding exists
between the NH and C=O groups of adjacent polypeptide chains. β-strands arrange
themselves in two ways in order to form β-sheet, namely parallel and anti-parallel.
3

Hydrogen bonded polypeptide chains extend in the same and opposite directions for
parallel and anti-parallel strands, respectively. Hydrogen bonding in parallel β-sheet is
distorted, making it less stable compared to the anti-parallel arrangement.

Figure 1.2. Top view of (A) antiparallel and (B) parallel β-sheet. R-groups extend out
from the β-sheet (purple spheres) and hydrogen bonding between adjacent chains are
shown as blue lines 1. From: Lehninger Principles of Biochemistry 6E, by David L.
Nelson and Michael M. Cox, Copyright 2013, by W.H. Freeman and Company. Used
by permission of the publisher.
The third category of secondary structure is called ‘turns’ or ‘loops’ that connect the αhelix and β-sheets in a protein. These are flexible and irregular bends containing at least
four amino acid residues hydrogen bonded to each other.
The elements of secondary structure of a protein combine together to form the tertiary
structure that is the three-dimensional folded protein. The tertiary structure ensures that
amino acids that are far apart in the sequence interact with each other via weak
interactions such as hydrogen bonding, electrostatic interactions and/or hydrophobic
interactions. Additionally, covalent bond formation is also observed in the form of
4

disulfide bonds between cysteine residues. The native folding of the protein establishes
a stable conformation with minimum free energy. The stable conformation of a folded
protein is attained when the hydrophobic amino acids form the interior of the protein
whereas the charged residues interact with the aqueous milieu. Another dimension of
stability is added by the formation of disulfide bonds. These covalent bonds are formed
by oxidation of sulfhydryl groups of cysteine residues and confer stability to the protein
in a relatively hostile extracellular environment.
Many proteins have multiple polypeptide chains (subunits) that interact with each other
via hydrogen bonding, electrostatic interactions and/or disulfide bonds. The subunits
associate themselves in a geometric arrangement and this spatial configuration forms
the quaternary structure of the protein. Proteins with multiple subunits are prevalent
mostly in metal binding proteins and enzymes. This provides a structural basis as a
binding site for metal or receptors for proper functioning of the protein/enzyme. The
quaternary structure of proteins forms the top of the protein-folding pyramid.

1.3 The Protein Folding Problem
Proteins need to fold into a three dimensional structure in order to function. The folding
process was initially postulated to be a template driven process. However the limiting
factor was the understanding as to how these “templates” formed. Anfinsen, in his
experiment with Ribonuclease A, showed that the protein can be denatured and
refolded and the process is reversible. In 1973, this became known as Anfinsen’s
hypothesis that the amino acid sequence of a protein determines its three dimensional
folding2. Although this hypothesis explained the thermodynamics of protein folding to
5

a great extent, the kinetics of protein folding was still unclear. In an attempt to
understand the protein folding process, the folding pathways need to be elucidated. If
proteins were to fold by randomly exploring all possible conformations, it would take
approximately billions of years to fold. However, protein-folding process is in the order
of microseconds. This inference, known as Levinthal paradox, lead to the hypothesis
that protein folding is an ordered process in which the formation of the native fold is
accompanied by the increase in conformational stability and decrease in free energy3.

1.3.1 Energetics of Protein Folding
The problem of protein folding is two-fold. The polypeptide chain needs to fold in its
lowest energy conformation and also in doing so, must fold rapidly. Hence, the protein
folding phenomena entails both thermodynamics and kinetics. The native state of the
protein is favored by only 5-15 kcal/mol free energy. This means that the free energy
of the native state of the protein is marginally lower than its denatured state. Protein
folding is an entropically unfavorable process that is compensated by the decrease in
enthalpy according to the second law of thermodynamics.
∆𝐺𝐺 = ∆𝐻𝐻 − 𝑇𝑇∆𝑆𝑆

(1.1)

Van der Waal forces and electrostatic interactions stabilize the native fold and are
unique for every protein. Proteins with conserved amino acid residues fold similarly,
and it arises from the fact that interactions that stabilize a particular fold become
destabilizing if the protein deviates from the native fold at physiological conditions.
Hence the free energy of a folded protein is at a ‘deep’ energy minimum that is
significantly distant from any destabilized protein folds. This gives rise to the classic
6

view that protein folding occurs via well-defined intermediates. Wolynes, Baldwin and
Dill postulated the landscape theory4-6 where the energy surface of a folding protein is
funnel shaped with the bottom of the funnel representing the native folded protein with
minimum global free energy (Figure 1.35). The total binding energy required for a
protein to fold is around 100 KBT, significantly larger than the barrier energy
(approximately 10 KBT)5. Proteins fold into many native-like conformations that are
close to the energy minimum before reaching the native fold. This is accounted for by
the rugged topography of the funnel landscape of protein folding. Hence, a protein
might also get trapped in a local minimum until it acquires the energy to overcome the
barrier energy and continue the folding process.

7

Figure 1.3. Schematic of funnel-like landscape of protein folding. Native fold signifies
lowest free energy5.
The kinetics of protein folding has been explained by the advent of experimental
techniques such as NMR, mass spectroscopy, and hydrogen exchange studies as well
as statistical mechanics theoretical studies. The progression of protein folding is
monitored using the variable – fraction of native contacts that goes from 0 in the case
of unfolded protein to 1 for the native state. For an unfolded protein, the number of
conformational ensembles is at a maximum that reduces throughout the folding process
8

and defines the shape of the folding funnel6. The normalized time taken (𝜏𝜏𝑓𝑓 ) for a
protein to fold and reach the global minima in the funnel is given by
𝑛𝑛

𝜏𝜏𝑓𝑓 = ∫𝑛𝑛 𝑓𝑓 𝜏𝜏(𝑛𝑛)𝑑𝑑𝑑𝑑

(1.2)

𝑢𝑢

where the depth of the energy landscape funnel (n) varies from the unfolded state of
the protein (𝑛𝑛𝑢𝑢 ) to the folded state (𝑛𝑛𝑓𝑓 ).

1.3.2 The Misfolded Scenario

The non-covalent interactions that stabilize protein structure are weak in nature. Hence
marginal deviation beyond physiological conditions leads to protein instability. In the
presence of destabilizing conditions such as removal of water and/or change in pH,
temperature, salt concentration etc, can lead to the inter-conversion of the protein from
its native state to unfolded state. The stability of a protein is expressed as the difference
between the free energy between the unfolded (U) state and the native fold (N).
(1.3)

𝑁𝑁 ⇌ 𝑈𝑈

The unfolded and native states have been studied experimentally using various
spectroscopic and calorimetric techniques. It has been shown that native protein
stability is not only due to the weak intermolecular interactions but also due to the
protein-solvent interactions. However, experimental and theoretical studies have
confirmed that protein structure is stabilized largely due to its hydrophobic interactions.
Calculations using lysozyme have shown that hydrophobic and electrostatic
interactions contribute 450 and 87 Kcal/mol respectively towards the free energy of
9

denaturation at room temperature7. These values are similar for globular proteins. At
room temperature, hydrophobic free energy is mainly entropic that can be compensated
by arranging the solvent molecule around the protein. Hence, hydrophobic interaction
favors burial of the solvent exposed protein surface.
Amidst all the favorable energy situations, the equilibrium of the protein towards the
native state shifts towards unfolding due to stresses that lead to misfolding of the
protein. Most globular proteins misfold by exposing the hydrophobic residues to the
aqueous milieu. These processes are irreversible for most cases. This irreversible
shifting of the equilibrium to the unfolded state leads to the hypothesis that misfolded
proteins are also thermodynamically stable. Misfolded proteins come together in highly
ordered forms to form protein aggregates. The aggregation pathway, stability of
aggregates and associated energetics have been explained by the Lumry-Eyring
framework as shown in scheme 1.4, where the native protein (N) undergoes reversible
conformational change to form transition ensemble (TS*) that forms an intermediate
(AI) after irreversible re-arrangement8. The misfolded intermediate AI associates with
an aggregated protein molecule Am, thereby continuing the aggregation process.
𝑁𝑁 ↔ 𝑇𝑇𝑆𝑆 ∗ ⟶ 𝐴𝐴𝐼𝐼

(1.4a)
(1.4b)

𝐴𝐴𝐼𝐼 + 𝐴𝐴𝑚𝑚 ⟶ 𝐴𝐴𝐼𝐼+𝑚𝑚

This framework is true for all first order reactions and can be extended for bimolecular
aggregation reactions as well. This stability of the aggregate form is attained by the
interactions between the aggregated protein and the destabilizing factors that help in
10

stabilizing the aggregate form. This is explained using the free energy diagram in
Figure 1.4

Figure 1.4. Free energy diagram of the Lumry-Eyring framework explaining the
energetics of protein aggregation and stability of aggregates. Kinetic energy barriers
are shown using curved lines8.

1.4 Protein Aggregation
The process by which proteins unfold and associate themselves in clusters is called
protein aggregation. The striking resemblance between different aggregated protein
forms in spite of disparate amino acid residues suggests a common underlying
mechanism of protein aggregation. This has led to the hypothesis of a generic
11

mechanism of protein aggregation. Destabilizing factors such as pH, temperature,
solvent etc. disrupt the native interactions within the protein as well as between the
protein and aqueous media. This exposes the hydrophobic amino acid residues leading
to aggregate formation. This mechanism of protein aggregation is termed as offpathway. Depending on the pathway followed, distinct aggregate forms are generated.
Energetically speaking, protein folding via the off-pathway route leads to aggregates
with an altered global minima (Figure 1.5)

12

Energy

Entropy

Figure 1.5. Energy landscape in case of protein folding and aggregation. Smooth
funnel is shown in light grey whereas the ruggedness increases with the complexity of
a protein leading to alternate folding forms (aggregates) shown in dark grey funnel9.

1.4.1 Types of Aggregates
Protein aggregates vary in morphology depending on the perturbation that leads to
aggregation10. Highly ordered aggregate forms, known as amyloid fibrils, have been
the focus of study for a long time due to their association with neurodegenerative
13

diseases such as Alzheimer’s and Parkinson’s disease11. Amyloid deposits are found
within the brain and also major organs such as the liver and the spleen. These
aggregates exhibit characteristic properties such as birefringence under plane polarized
optical microscope, cross-beta X-ray diffraction pattern and tight binding with amyloid
specific dyes such as thioflavin T12. Information gathered using these characterization
methods reveal that amyloids are rich in β-sheet structure that runs perpendicular to the
fibril axis13. Amyloid fibrils have been observed using many unrelated proteins14 and
polymers suggesting a generic mechanism of aggregation15, although the propensity of
fibril formation varies with proteins and is believed to be sequence-dependent16. The
mechanism of fibril formation highlights the formation of intermediates and oligomers.
They accelerate fibril growth both by nucleation-dependent and chain polymerization
methods17.
However apart from fibrils, other disordered aggregate forms (loosely termed as
amorphous aggregates) have been found both in in vitro and in vivo studies18. These
disordered aggregates have been broadly divided into particulates and spherulites19.
Particulates20 are bead-like amorphous protein aggregates that have been found
predominantly in β-lactoglobulin under thermal and pH stress21. This form of aggregate
has not yet been associated with any medical relevance, however protein particulate
formation is of great concern in the food industry. When heated, the protein forms
clear fibrillar gels away from its isoelectric point whereas at the isoelectric point, it
forms particulates. These monodisperse particulates are a result of partial denaturation
of β-lactoglobulin with average sizes varying between 1 to 1.5 μm. The size of these
14

particulates changes with heating rate and temperature. Rapidly heating the protein to
100 oC results in smaller particulates with average size of 500 nm, whereas slow heating
(1 oC/min) to 80 oC leads to bigger size distribution22. The mechanism of protein
aggregation to form particulates has been elucidated in some studies. One model
suggests that it is similar to a free radical polymerization method with initiation,
propagation and termination steps. In this scenario, cysteine residues have been
hypothesized to play the role of free radicals in disulfide-rich proteins. Another model
explains protein particulate formation using nucleation and growth mechanism.
Unfolded proteins form the nucleus that stimulates the formation of aggregates and
increases the kinetics of aggregation. This method was used to explain the varying
particle size of the particulates with respect to change in pH and temperature.
Spherulites are another form of disordered aggregates that exhibit a characteristic
maltese-cross pattern when viewed under the cross polarizers of an optical
microscope23. These are radial arrangements of amyloid fibrils with a central core.
However, the reason behind the equilibrium shift from amyloid fibrils to spherulites
and its energetics is still unknown. Spherulitic growth has been observed in lysozyme,
β-lactoglobulin, Aβ-42 and insulin among other proteins24. They also have been
observed within amyloid plaques of Creutzfeld-Jacob disease, Down’s syndrome and
rat model Alzheimer’s disease25.

1.4.2 Protein Aggregation and Neurodegenerative Diseases
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease,
Amyotrophic Lateral Sclerosis (ALS) and other forms of dementia are a class of late
15

onset diseases that affect the central nervous system26. These diseases are characterized
by the presence of abnormal proteinaceous deposits in the brain. Morphology of these
deposits are predominantly fibrillar with characteristic properties common for all
neurodegenerative diseases. These deposits are formed by misfolded and aggregated
proteins. Proteins aggregate due to mutation in the sequence, genetic alteration of the
protein or external stresses and aging. Protein folding in diseased condition has been
proposed to be a cause of neurodegeneration, rather than an effect. This is supported
by pathological and genetic information about the disease, animal model studies and
also biophysical characterization of aggregated proteins in vitro27.
The most common form of neurodegenerative disease is ALS. It was first described by
French neurobiologist Jean-Martin Charcot in 1869 and was known as Charcot’s
sclerosis until the 1930’s when baseball player Lou Gehrig was affected by this
debilitating condition28. ALS is now familiarly known as Lou Gehrig’s disease. The
hallmarks of this fatal condition are progressive muscle weakness, spasticity,
hyperreflexia, and atrophy due to degeneration of motor neurons in the brain and spinal
cord29. 5-10% of this disease is linked to genetic mutations meaning that they are
familial, however almost 90% is sporadic in nature.
Mutations in the superoxide dismutase 1 (SOD1) protein contribute to about 20% of
familial ALS cases. SOD1 is a 32 kDa homodimeric metallo-enzyme that is
predominantly found in the cytosol30. Each subunit in the homodimer, form eight
stranded Greek key β-barrel containing active sites for binding copper and zinc31. The
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main function of SOD1 is free radical scavenging in the body, thereby preventing
oxidative and mitochondrial damage to cells.
Of the more than 153 SOD1 mutants that have been studied so far, most of them are
missense mutations, with only a few C-terminal truncated forms32. As a part of the
cells’ protein degradation system, misfolded proteins are targeted through
ubiquitylation. These misfolded proteins have toxic effects on the proteosomal pathway
and autophagy leading to the presence of ubiquitylated aggregates in patient brains33.
The relationship between presence of misfolded SOD1 in the brain and occurrence of
ALS is unknown. However, it is established that aggregated SOD1 confers a toxic gainof-function rather than a loss of normal function. This property is independent of the
various SOD1 mutants that have been reported so far. The observations supporting this
argument have been drawn from mice model studies34. However, SOD1 null mice did
not develop the disease at all. Transgenic mice studies have been carried out for more
than 100 mutations and all SOD1 mutant aggregates have been ubiquitin positive with
presence of intracellular aggregates of the protein in motor neurons and astrocytes.
Effects of SOD1 mutations are disparate where some mutants (G37R) do not lose
normal activity. Additionally, no correlation has been found between activity of SOD1
protein and the disease onset and progression. These lack of correlations make the
scenario of understanding how SOD1 causes motor neuron death highly overwhelming.
Apart from SOD1, several other proteins have been identified within the
pathophysiology of ALS. Approximately 90% of sporadic ALS cases have been
identified to be a result of mutations in the TARDBP gene35. This leads to aggregation
17

of TAR DNA binding protein (TDP-43) and is a major component of ubiquitinated
inclusions in ALS patients. Aggregates of the wild type TDP-43 are also found in the
motor neurons of the spinal cord, hippocampal neurons and glial cells of various motor
neuron diseases. Hence, diseases linked to TDP-43 deposits have been termed as TDP43 proteinopathies.
TDP-43 is a 43 kDa nuclear protein that binds to the RNA and DNA via its RNA
recognition motifs (RRM). The entire protein has 2 RRMs, a nuclear localization
sequence (NLS) and a glycine rich flexible C-terminal that mediates protein-protein
interactions. The main function of TDP-43 is RNA splicing regulation and modulation
of microRNA biogenesis32. It is also involved in cytoplasmic stress granule response
and is a key component of dendritic RNA transport granules in neurons.
Currently around 38 mutations in the TARDBP gene have been reported in ALS cases
and most mutations are on the region encoding the C-terminal end of the protein36. In
the diseased conditions, TDP-43 localizes to the cytoplasm from the nucleus
accompanied by C-terminal degradation of the protein. Hyper-phosphorylated forms of
the protein are a common hallmark of ALS, and the extent of disease progression is
generally gauged by the spread of proteinaceous deposits from spinal and cortical
neurons to other cortical regions37. However, the relationship between TDP-43
proteinopathy and pathology is still unknown. A number of studies using animal
models have confirmed that TDP-43 aggregation not only leads to toxic gain-offunction (like SOD1), but also causes loss of normal function of the protein. While both
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loss and gain plays a role in disease progress, the link between the two is yet to be
established.

1.5 The Model Proteins
Protein folding is a complex process and the complexity increases when they misfold
and aggregate. The main aim of studying the molecular mechanism of protein
aggregation is to understand the disease process associated with these proteins for
possible therapeutics. Owing to the complexity of disease-related proteins and the vast
pool of unanswered questions, dissection of the molecular mechanism behind
aggregation is very difficult. Therefore it is worthwhile to study the mechanism of
aggregation in proteins that are well characterized, in order to provide a broader picture
of the aggregation process. The motivation of studying model proteins and
extrapolating the information to disease causing complex proteins is due to the generic
mechanism of aggregation that is observed among unrelated proteins. A large number
of proteins such as carbonic anhydrase, myoglobin, β-lactoglobulin, lysozyme, bovine
serum albumin (BSA), insulin etc. have been candidates for model protein. All these
proteins aggregate under destabilizing conditions that can be controlled and the
aggregation mechanism can be elucidated.
We chose to study human insulin, lysozyme, and BSA as our model proteins due to
their diversity in molecular weight, disulfide bond status and secondary structure. Also,
all three proteins have a very high propensity to aggregate and two of these (insulin and
lysozyme) have been linked to some form of amyloid diseases.
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1.5.1 Human Insulin
Insulin was discovered in 1920 by Dr. Frederick Banting, and is considered as one of
the most important advances in the field. This protein played a pivotal role in advancing
knowledge in peptide chemistry, structural biology and recombinant DNA technology.
This 5.8 kDa hormone continues to be a subject of research owing to its use by insulindependent diabetes patients and its aggregation propensity under various conditions in
vivo and in vitro. Still today, insulin serves as a model protein for studying protein
aggregation due to its small size, presence of highly conserved disulfide bonds and well
defined secondary structure (Figure 1.6).

Figure 1.6 Ribbon structure of human insulin hexamer. Figures generated using
PyMOL 1.3 from PDB file 1AI0
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Insulin is a 51 amino acid residue polypeptide with 2 chains A and B38. It is synthesized
in the body as proinsulin (longer chain) and is cleaved off to release the active insulin.
This messenger hormone is secreted by the pancreas into the blood where it binds to its
receptor and helps in monitoring blood glucose in the body.
Comparison of phylogenetic data and studies using various biophysical techniques
show that the majority of amino acid residues are conserved in the insulin structure,
across 100 vertebrates that were studied39. The conserved areas are those that bind to
the insulin receptor for proper functioning of the protein, suggesting that the structure
and function have been conserved throughout evolution. The structural features that
have been conserved are the chain length, position as well as number of cysteine
residues and 16 of the 51 amino acid residues.
As with other eukaryotic organisms, insulin undergoes post-translational modifications
that are required for its native fold as well as function. One of the important
modifications is the formation of disulfide bonds that help maintain the stability and
biological activity of insulin. This is ensured by the fact that insulin disulfides are
thoroughly conserved between residues A6-A11, A7-B7 and A20-B19 as they hold the
structure of the protein. The A chain forms a U-shape and sits on the B chain with
hydrophobic interactions between 5 conserved leucine residues holding them together.
The importance of each of the conserved disulfide bonds has been elucidated using
protein-engineering methods. Substituting the cysteine in the A6-A11 bond leads to
decreased binding affinity of insulin. This has been attributed to the loss of hydrophobic
interaction in the A chain that majorly rests on the disulfide bridge between A6-A11.
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Substitution of cysteine in A7-B7 has led to diverse outcomes. Studies have shown that
these insulin analogs show substantially low biological activity, binding affinity and
40% potency in mouse convulsion assay. Deletion or substitution of the C-terminal
disulfide bridge A20-B19 has led to very poor expressions in yeast systems. Overall,
the inter-chain disulfide residues help in maintaining the parallel orientation of chains
A and B whereas the intra-chain disulfide bridge directs the folding of the protein by
bringing the N and C terminal in close proximity that forms the insulin receptor binding
site.

1.5.2 Lysozyme
Lysozyme was accidentally discovered by Dr. Alexander Fleming in 1921 during his
search for medical antibiotics. It is a 14.3 kDa globular protein with 129 amino acid
residues. The relatively small protein is abundantly found in tears and hen egg white.
Lysozyme is a glycosidase enzyme that attacks the peptidoglycan cell wall of bacteria
and hydrolyses them, thereby imparting anti-bacterial properties.
This protein consists of two subunits, one predominantly α-helical and the other mainly
β-sheet structure (Figure 1.7). The three-dimensional structure of lysozyme is stabilized
by four disulfide bridges between C6-C127, C30-C115, C64-C80, and C76-C94. The
disulfide bridge between C6-C127 keeps the N and C-terminal of the protein in close
contact thus maintaining the protein stability and fold. Hence C6-C127 is partially
solvent-exposed40. However, the other three disulfide bonds are buried within the
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hydrophobic core of the protein. Lysozyme serves as a model protein, not only because
it is well characterized but also because it has been linked with systemic amyloidosis.

Figure 1.7 Ribbon structure of hen egg-white lysozyme. Figures generated using
PyMOL 1.3 from PDB file 1UCO.

1.5.3 Serum Albumin
Serum albumin is abundant in the circulatory system with a concentration of 35-50
mg/mL in the blood plasma. It is a 66 kDa protein that transports various endogenous
and exogenous compounds such as fatty acids, metals, amino acids, drugs etc. through
the blood stream41. Transportation of various ligands occur by the binding of waterinsoluble molecules to the hydrophobic pocket of BSA. Apart from being a transport
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protein, BSA also helps in maintaining blood pH and osmotic pressure. BSA is majorly
α-helical with three homologous domains (I, II and III), 17 intra chain disulfide bridges
and one free cysteine at position 35. Most of the disulfide bonds are buried within the
core of this hydrophobic protein around neutral pH and the native fold is characterized
by formation of nine disulfide loops. However, with increase in pH and temperature
beyond physiological, some disulfide bridges become solvent accessible due to partial
unfolding of the protein40.
BSA maintains 76% homology with human serum albumin suggesting the importance
of conserving the function of serum albumin protein. Serum albumin is considered a
model protein due to its high molecular weight, high hydrophobicity and presence of
large number of disulfide bonds that stabilize the structure of this globular protein.

24

Figure 1.8 Ribbon structure of bovine serum albumin. Figures generated using
PyMOL 1.3 from PDB file 4F5S.

1.6 Aims of Research
Protein misfolding and aggregation have been linked to Alzheimer’s disease,
Parkinson’s disease, Amyotrophic Lateral Sclerosis (ALS) and other forms of dementia
that are neurodegenerative in nature. The molecular mechanism of these diseases needs
to be investigated in order to continue the search for therapeutics. The main players
identified in these diseases are SOD1, TDP-43, α-synuclein, and Aβ-42, among others.
However, information on the structure and folding of these proteins are very limited.
This makes understanding the aggregation process of these proteins and its relationship
to diseases very complex.
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Proteins aggregate due to various destabilizing effects, and one of the most crucial
destabilizing factors is breakage of disulfide bonds. Disulfide bonds are covalent
posttranslational modifications that predominantly have two functions. First, they
influence the thermodynamics of protein folding by destabilizing and lowering the
entropy of the unfolded protein and shifting the equilibrium to the native fold. Second,
they maintain protein integrity, protect against proteolysis and increase shelf life of
proteins. However, the reducing cytosolic environment or deviations in pH and
temperature compromise the disulfide bonds that trigger protein aggregation.
The main aim of this research is to understand the effects of reducing environment on
the aggregation kinetics of the model protein insulin (Chapter 3). Understanding the
aggregation of insulin in the presence of a reducing agent would be helpful since the
protein is known to aggregate under storage conditions via disulfide bond scrambling.
Insulin is also a disease related protein since it aggregates at the site of repeated
injections in diabetes patients leading to injection amyloidosis. Aggregated insulin
becomes the nucleus for further protein aggregation. We studied the kinetics of
nucleation dependent insulin aggregation using preformed insulin seeds.
Alternate forms of protein aggregation have been found within amyloid plaques in vivo,
however their toxicity is still unknown. Diverse forms of protein aggregates have also
been observed in in vitro studies using various proteins. The possibility of formation
of alternate protein aggregates leads to the second aim of this research (Chapter 4). It
is to characterize the morphology of different types of aggregates formed at diverse pH
and temperature range, and correlate them to the cellular toxicity.
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The aim of studying protein misfolding and aggregation is to understand the
mechanism of protein aggregation and stabilize the native fold of the protein. In the
last part of this research, we study the effect of various macromolecular crowding
agents on model protein - lysozyme aggregation (Chapter 5). These crowding agents
are high molecular weight polymers that are known to protect the protein structure
against aggregation and thus increase stability. We study the effect of these
macromolecules on lysozyme aggregation under mild reducing as well as thermal
stress, in order to investigate the protective role of these crowding agents against
disulfide bond scrambling and aggregation.
Insulin aggregation kinetics under various conditions was studied using UV/Visible
Spectroscopy, Fluorescence Spectroscopy, Fourier-transform infrared spectroscopy
(FTIR), Mass Spectrometry (MALDI-MS). Morphology of the aggregates and
nucleation dependent insulin aggregation was investigated using Scanning Electron
Microscopy and Atomic Force Microscopy. All techniques used to accomplish the aims
of this research are discussed in Chapter 2
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Chapter 2. Methods
Biophysical and biochemical characterization of protein aggregation kinetics along
with its morphology was carried out using various spectroscopic, spectrometric and
microscopic techniques. Mass assisted laser desorption mass spectrometry (MALDIMS) and gel electrophoresis was used to analyze various species of protein aggregates
present. Protein aggregation was monitored by measuring turbidity of protein solution
at 600 nm using UV-visible spectroscopy. Protein unfolding, conformational change
and exposure of hydrophobic pocket was monitored using intrinsic and extrinsic
fluorescence. Secondary structure of protein aggregates were probed using Fourier
transform infrared spectroscopy (FTIR). Morphology of protein aggregates was
determined using scanning electron microscopy (SEM) and atomic force microscopy
(AFM). The basic working principle of the techniques is discussed below.

2.1 Spectroscopy
Spectroscopy entails the study of the interactions between electromagnetic waves and
molecules. Electromagnetic waves are radiations with electrical and magnetic forces.
Spectroscopic measurements involve the effects associated with the electrical effects
of the electromagnetic spectrum. The path of the electromagnetic wave is traced as a
sinusoidal curve (Figure 2.1) where λ is the wavelength and A is the maximum
amplitude of the wave.
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Figure 2.1 Wave-like propagation of light. Light propagates in a sinusoidal path where
one cycle is the distance between two troughs and the depth of a trough denotes the
amplitude.

The electromagnetic spectrum spans a vast energy range between 10-5 nm (cosmic rays)
to 1014 nm (radio waves). Application of spectroscopy for studying proteins involves
using radiation within the ultraviolet (200-380 nm), visible (380-780 nm) and infrared
(780-3000 nm) regions1.

2.1.1 Ultraviolet (UV)-Visible Spectroscopy
UV-Visible spectroscopy is a form of absorbance spectroscopy that constitutes
electromagnetic radiations from 200-780 nm (UV and visible). This form of
spectroscopy assumes light as a stream of particles (photons) instead of waves.
Molecules exist with discrete energy levels. Change in energy levels occurs in the
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molecule by absorption of energy in the form of a photon. The energy (E) of a photon
is defined as
𝑐𝑐

(2.1)

𝐸𝐸 = ℎ 𝜆𝜆

where h is the Planck’s constant, c is the speed of light and λ is the wavelength of
energy used.
The main principle of absorption spectroscopy is explained by Beer-Lambert’s Law. It
states that the fraction of incident monochromatic light that is absorbed by a molecule
is proportional to the number of molecules in its path (Figure 2.2)

Figure 2.2 Schematic representation of Beer-Lambert’s Law. Incident light (Io) is
absorbed by a solution and transmitted light (I) leaves the solution. Concentration (C)
of the solution is calculated using the path length l and extinction coefficient of the
solute in the solvent.
When light passes through a solution, the amount of light absorbed or transmitted is an
exponential function of the concentration of solute in the solution2. Amount of light
absorbed also depends on the length of the path of radiation through the solution.
Mathematically, this can be explained as
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log

𝐼𝐼𝑜𝑜
𝐼𝐼

(2.1)

= 𝜀𝜀𝜀𝜀𝜀𝜀

Where 𝐼𝐼𝑜𝑜 is the intensity of the incident light, 𝐼𝐼 is the intensity of light transmitted

through the solution, c is the concentration of solute in moles/L, 𝑙𝑙 is the path length of

the sample in cm and ε is the molar absorptivity or molar extinction coefficient in M1

cm-1. Molar extinction coefficient signifies how strongly a molecule absorbs light

within a particular solvent at a specific wavelength. The logarithm of the ratio of the
intensity of incident light to that of transmitted light is the absorbance (A) of the
molecule. Hence, equation 2.1 can be rewritten at
(2.2)

A = 𝜀𝜀𝜀𝜀𝜀𝜀

Molar absorption coefficient plays a very important role in analyzing protein using UVVis spectroscopy. Proteins absorb energy between 275 and 290 nm (Near-UV range
because of the absorbance of aromatic residues Tryptophan (Trp), Tyrosine (Tyr), and
Phenylalanine (Phe). Cysteine absorbs to a minor extent as well. Absorbance of
aromatic residues depends on the environment and it is red-shifted when the
environment changes from polar to non-polar. In the near-UV range, molar absorbance
of Phe is significantly smaller than Trp and Tyr. Calculating the molar extinction
coefficient from the amount of Trp, Tyr and Cys residues at a particular wavelength
provide the basis of calculating protein concentration within aqueous media3.
Absorbance of a molecule linearly depends on the concentration of the solute, making
this technique suitable for quantitative measurements. The strength of absorbance not
only depends on the chemical structure of the solute, but also on the environment
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around the solute. Hence, this technique can be effectively used to measure protein
concentrations and quantify protein aggregation. Protein aggregation can be quantified
by measuring the absorbance of aggregates within the visible range at 350 or 600 nm
(depending on the hydrodynamic radius of the aggregates). This is based on the
increase in turbidity and absorbance of protein solution with increase in aggregated
species.

2.1.2 Fluorescence Spectroscopy
Emission of light from substances occurs at their electronically excited states. This
phenomenon is known as luminescence. Luminescence has two forms – fluorescence
and phosphorescence, depending on the nature of excited state of the substance. In the
case of fluorescence, the excited electron reaches a higher energy orbital with another
electron of opposite spin in the ground state. This leads to return of the excited electron
to ground state with emission of photon at a rate of approximately 108 s-1. Fluorescence
is indicated in a Jablonski diagram (Figure 2.3) as a straight line going down along the
energy axis between electronic states. Fluorescence is a relatively slow process hence
most likely observed between the first excited state and the ground state of a molecule.
Energy of photons emitted during fluorescence is equal to the energy difference
between corresponding Eigen states, however the energy of the emitted photon is less
than that of the excited photons due to energy lost in internal conversion. This
difference of energy between absorption and emission is known as Stokes shift.
The electronic states are depicted by So, S1, S2 etc where the molecules can exist in a
number of vibrational energy levels depicted by Vo, V1, V2 etc. After absorbing light
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in the form of a photon, molecules are excited to a higher energy level (S1, S2 or higher).
The molecule relaxes instantly (in most cases) and reaches a lower vibrational energy
level by a process called internal conversion, which precedes emission. Hence,
emission occurs from a thermally equilibrated excited state4.

Figure 2.3 Simplified Jablonski diagram showing the possible transitions during
intrinsic fluorescence. Solid purple line shows absorption, followed by internal
conversion, fluorescence (solid green line) and phosphorescence (solid red line).
Adapted from Principles of Fluorescence Spectroscopy. Third Edition. Lakowicz, J.R.

Molecules that exhibit fluorescence are known as fluorophores. Intrinsic fluorophores
are those that exhibit fluorescence naturally. Intrinsic fluorescence is dominant in the
aromatic residues of amino acids: mainly indole group of tryptophan, followed by
tyrosine and phenylalanine to a lesser extent (Figure 2.4). This is because tryptophan
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has the highest absorption coefficient (5.6 x 103 M-1cm-1) followed by tyrosine (1.4 x
103 M-1cm-1) and phenylalanine (0.2 x 103 M-1cm-1). At 280 nm, only tryptophan and
tyrosine absorbs and hence the observed fluorescence is contributed by both amino
acids. Unlike tyrosine, fluorescence of indole group of tryptophan residue may be blueshifted (shorter wavelength) when the residue is buried within the native protein,
whereas red-shift is observed in an unfolded protein. This property is used to measure
the kinetics of protein unfolding and aggregation. In a completely folded native protein,
intrinsic fluorescence shows an increasing trend due to buried tryptophan residues. In
an unfolded protein, tryptophan residues are exposed to the aqueous environment
leading to fluorescence quenching.

Figure 2.4 Structures of amino acid residues that exhibit intrinsic fluorescence. Figures
generated using Chem3D Pro 12.0
Extrinsic fluorophores are mostly covalently attached to proteins or ligands for
fluorescence energy transfer and anisotropic measurements. However, a class of
extrinsic fluorophores are those that interact with proteins and its degradation products
via non-covalent interactions, mainly electrostatic and hydrophobic. These
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commercially available fluorophores (dyes) are highly sensitive to the environment.
These dyes have been extensively used in protein characterization to monitor protein
folding and unfolding, to detect molten globule intermediates, to determine mechanism
of aggregation and to assess surface hydrophobicity. Dyes used for protein
characterization are tabulated in Table 2.1 and their structures are shown in Figure 2.5.
Proteins are characterized using dyes in conjunction with steady state fluorescence
spectroscopy. Light is absorbed by the dye that leads to excitation and transfer of
electrons from the ground state (So) to higher singlet excited state. Excitation is
followed by loss of energy by several processes, leading to Stokes shift. These
processes are vibrational relaxation, internal conversion, solvent relaxation, and
intermolecular charge transfer (ICT) or twisted intermolecular charge transfer (TICT).
These electronic transitions are explained using a schematic in Figure 2.6. After the
electron reaches the lowest vibrational energy level of S1 or S(T)ICT in case of charge
transfer process, the molecule relaxes to ground state by fluorescence emission or nonradiative decay occurs.
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Table 2.1. Extrinsic fluorescent dyes used for protein characterization and aggregation.
Adapted from Hawe, A. et.al. (2007) Pharm.Res. 25(7): 1487-1499.
Dye

Application

Stock

Extinction

Excitation Emission

Solution

Coefficient (nm)

(nm)

(M-1cm-1)
ANS

Surface

Ethanol,

5000 at 350 350-380

hydrophobicity,

Aqueous

nm in water

475-505

protein
folding/unfolding
kinetics
Bis-

Surface

Ethanol,

16790

at 385-400

ANS

hydrophobicity,

Aqueous

350 nm in

480-515

water

protein
folding/unfolding
kinetics,
conformational
tightening
ThT

Aggregate

Ethanol

26620

morphology

416 nm
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at 450

480-490

Figure 2.5 Structure of extrinsic fluorescent dye ANS, Bis-ANS and ThT, used for
protein characterization aggregation studies. Structures made using Chem 3D Pro 12.0.

These electronic transitions are accompanied by change in dipole moment of the dye.
If the solvent also possesses a dipole moment, the solvent molecules reorient around
the dye molecules to energetically favorable positions. This causes lowering of energy
level S1 and energy level So rises, leading to increase in Stokes shift. This is known as
solvent relaxation and depends on solvent polarity. Fluorescence properties of extrinsic
dyes are also dependent on ICT and/or TICT. In both situations, an electron is
transferred from a donor (amino group) to an acceptor (aromatic group) within the
excited dye molecule. Both ICT and TICT induce charge separation causing an increase
in dipole moment of the excited state S(T)ICT. T(ICT) is favored in polar solvents and
relaxation occurs by solvent relaxation or non-radiative decay. This explains the weak
fluorescence of dyes in polar solvents. Another factor that alters dye fluorescence is
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hydrogen bonding. Solvents that are capable of hydrogen bonding shift the emission
spectra of a dye significantly.

Figure 2.6 Simplified Jablonski diagram showing the energy levels of the ground state
and excited state, as well as electronic transitions in case of fluorescent dyes.
Radiationless vibrational relaxation and internal conversion process (dashed arrows),
solvent relaxation and TICT (dotted arrows) and fluorescence (solid arrows) are the
possible outcomes when electrons absorb energy and reach excited state S1, S2 from
ground state So. Adapted from Hawe, A. et al. (2007) Pharm.Res. 25(7): 1487-1499
In the 1950s chemists found that introducing various substituted aniline groups in
naphthalene derivatives, resulted in molecules like 1-anilinonaphthalene-8-sulfonate
(ANS) and its dimeric analog 4,4’-bis-1-anilinonaphthalene-8-sulfonate (Bis-ANS).
ANS and Bis-ANS fluorescence is sensitive to solvent polarity, viscosity and
temperature. Blue shift and increase in quantum yield occurs with decreasing dielectric
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constant of solvent (decrease in polarity). In the excited state, both dyes undergo TICT
with charge transfer from amino-aryl group to sulfonated naphthalene group.
Fluorescence properties of ANS and Bis-ANS depend on their interaction with protein
molecules. Both dyes bind to proteins via hydrophobic and electrostatic interactions.
Ion pairing between negatively charged sulfonate groups with positively charged amino
acids (lysine, histidine, and arginine) is dominant in ANS-protein interaction. These
ion pairs are stabilized by van der Waals interactions. In case of Bis-ANS, hydrophobic
interaction is more dominant. While ANS is used to determine the exposure of
hydrophobic residues in a protein molecule during the aggregation process, Bis-ANS
fluorescence also depends on conformational tightening of the protein5.
ANS and Bis-ANS are mainly used to monitor the mechanism of protein unfolding
during aggregation and the conformation of the resultant aggregates respectively.
Understanding the aggregation mechanism is accompanied by the question of
aggregate morphology. Thioflavin T (ThT) is a classic dye used to understand whether
protein aggregates are fibrillar structures or disordered amorphous forms. The dye
binds to both aggregate forms with significant differences in the fluorescence intensity.
When ThT binds to fibrils, fluorescence intensity is almost 10 times when compared to
amorphous aggregate binding. Quantum yield of ThT is affected by solvent viscosity
and rigidity of the microenvironment. The dye is almost non-fluorescent in solvents of
low viscosity. This has been explained by the formation of a non-fluorescent TICT state
accompanied by a change in the angle between benzothiazole and the benzene ring
from 37o to 90o 5.
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ThT was originally used as a histochemical stain for amyloid-like deposits in tissues.
Later the application was extended for quantification of amyloid fibrils in vitro.
Amyloid fibrils are highly ordered protein aggregates that are rich in β-sheet structures.
In the presence of these filamentous structures, ThT exhibits absorption peak at 450
nm and emits at 480 nm. The fluorescence is due to the formation of micelles binding
to grooves of the fibrils. These grooves have a cavity size of less than 8 Å. Hence,
amorphous aggregates with a similar cavity size also lead to fluorescence due to dye
binding6. In bound form, ThT remains in flat conformation leading to increase in
quantum yield due to inhibition of S(T)ICT state.

2.1.3 Fourier-Transform Infrared Spectroscopy
Infrared spectroscopy is a classical method for secondary structure determination of
proteins due to its sensitivity to the chemical composition and architecture of
molecules. Absorption of energy in the infrared region excites the vibrational
transitions in a molecule. The vibrational frequency and probability of absorption
depend on the polarity and strength of vibrating bonds, which is, related to the interand intra-molecular effects. The position of absorption band in infrared spectroscopy
is determined by vibration masses, type of bonds involved, and position of electron
accepting and electron donating groups. The strength of absorption increases with
increase in polarity of the vibrating bonds.
In 1950, Elliot et al.7 demonstrated that there is an empirical relationship between the
vibrational frequencies of amide I and amide II absorptions of a protein and its
secondary structure8, 9. Studies with proteins show that predominantly α-helical
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proteins exhibit amide I and amide II spectral ranges of 1652 to 1657 cm-1 and 1545 to
1551 cm-1 respectively, in aqueous medium. Proteins with β-sheet structures absorb
between 1628-1635 cm-1 and 1521-1525 cm-1. Secondary structures such as turns, loops
and random structures also absorb at specific wavenumbers. A list of wavenumbers and
assignments to secondary structures in water is shown in Table 2.2.
Miyazawa and co-workers later described the amide modes in the 1960s. It was
elucidated that absorption in the amide I range was 80% due to C=O stretching in the
amide group. The other 20% could be attributed to C-N stretching vibration. The amide
II absorption arises from N-H bending and C-H stretching vibrations. The frequency of
the amide I and II absorptions also depends on the strength of hydrogen bonds involved
in amide C=O and N-H groups. Each amide group is associated with distinct secondary
structures in a protein, due to its association with characteristic hydrogen bonding
pattern between C=O and N-H groups. This forms the basis of distinct absorption bands
for each secondary structure of proteins and is the main principle behind using infrared
spectroscopy for secondary structure determination10, 11.
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Table 2.2. Deconvoluted amide I band frequencies and assignments to secondary
structure for protein in water. Adapted from Kong, J. et.al. Acta. Biochim.et.
Biophys.Sin. (2007), 39(8): 549-559
Mean frequencies in H2O

Secondary Structure Assignment

1624±1.0

β-sheet

1627±2.0

β-sheet

1633±2.0

β-sheet

1638±2.0

β-sheet

1642±1.0

β-sheet

1648±2.0

Random

1656±2.0

α-helix

1663±3.0

310 Helix

1667±1.0

β-turn

1675±1.0

β-turn

1680±2.0

β-turn

1685±2.0

β-turn

1691±2.0

β-sheet

1696±2.0

β-sheet
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Figure 2.7 Scheme of a Fourier transform infrared spectrometer. Adapted from Barth,
A. Biochim.et.Biophys.Acta (2007), 1767: 1073-1101

Modern infrared spectrometers are Fourier-transform infrared spectrometers (FTIR).
The detector signal of the spectrometer is related by a Fourier transformation to the
measured spectrum. The scheme of an FTIR spectrometer is shown in Figure 2.7.
Quantification of protein secondary structure using FTIR is based on the assumption
that any protein can be considered as a linear sum of individual secondary structure
elements. The percentage of these elements is related to the spectral intensity. The
simplicity of using FTIR to determine secondary structure of a protein is made complex
by side-chain absorption. The contribution of side-chain in a typical globular protein is
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roughly between 10-30% of the overall absorption. This is superimposed on the peptide
absorption and might lead to changes in the amide I spectral band. Amino acid residues
like lysine, arginine, histidine, asparagine, and glutamine absorb intensely in the amide
I region. Hence it is important to quantify the amino acids in side-chains in order to
refine the secondary structure determination of proteins8.

2.2 Microscopy
Proteins aggregate due to aberrant misfolding. Although the underlying mechanism of
protein aggregation is similar, they form diverse aggregate forms. The pathophysiology
of protein aggregation diseases is also dependent on the morphology of these
aggregates that may influence their toxicity. The structure and morphology of these
aggregates have been revealed by microscopy techniques such as scanning electron
microscopy (SEM), transmission electron microscopy (TEM), and atomic force
microscopy (AFM).

2.2.1 Scanning Electron Microscopy
Scanning Electron Microscopy (SEM) bombards a beam of high-energy electrons on a
sample surface. The electron beam interacts with the solid sample and emit electrons
from the sample. The type of electron emission is dependent on the interaction type and
the depth of penetration of the incident electrons, as shown in Figure 2.8. As shown in
the figure, emission of secondary and backscattered electrons is captured by the SEM
detector. Secondary electrons are produced when an incident electron excites an
electron in the sample and loses most of its energy in the process. The excited electron
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moves towards the surface of the sample undergoing elastic and inelastic collisions
until it reaches the surface, where it can escape if it still has sufficient energy.
Production of secondary electrons is very topography related and is used to understand
sample morphology. Backscattered electrons consist of high-energy electrons
originating in the electron beam that are reflected or back-scattered out of the specimen
interaction volume. The production of backscattered electrons varies directly with the
specimen's atomic number. These differing production rates cause higher atomic
number elements to appear brighter than lower atomic number elements, revealing the
composition of a specimen12.

Figure 2.8 Interactions of incident electron beam with solid sample. Incident electron
beam leads to emission of electrons from the sample depending on the interaction.
Adapted from Scanning Electron Microscopy and X-ray Microanalysis. Third
Edition Goldstein, J., Newbury, D.E., Joy, D.C., Lyman, C.E., Echlin, P., Lifshin,
E., Sawyer, L., Michael, J.R.
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The working of the microscope involve four basic steps (i) Stream of electrons is
formed by the electron gun in vacuum, (ii) Electrons are accelerated towards the
samples (with a positive electrical potential), (iii) Electrons are confined and focused
using metal apertures and electromagnetic lenses into a thin monochromatic beam, and
(iv) The sample is irradiated by the beam and the interactions are detected and
transformed into an image. The converging of the electron beam after passing through
various electromagnetic lenses is shown in Figure 2.9.
While imaging biomolecules such a proteins using SEM, it is important that the sample
does not degrade due to the heating effects associated with the high-energy electron
bombardment. This necessitates the use of a cold field emission (FE) electron gun. The
FE electron gun (cathode) is usually a wire of single-crystal tungsten fashioned into a
sharp point and spot welded to a tungsten hairpin. The significance of the small tip
radius, about 100 nm or less, is that an electric field can be concentrated to an extreme
level. If the tip is held at negative 3-5 kV relative to the anode, the applied electric field
at the tip is so strong that the potential barrier for electrons becomes narrow in width.
This narrow barrier allows electrons to “tunnel” directly through the barrier and leave
the cathode without requiring any thermal energy to lift them over the work function
barrier.
When nonconductive specimens such as biomolecules are directly illuminated with an
electron beam, the electrons collect locally (specimen charge-up), thus preventing
normal emission of secondary electrons. This charge-up causes some unusual
phenomena such as abnormal contrast and image deformation and shift. Charging of
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specimen is avoided by coating the sample with a conductive material such as platinum.
The average coating thickness varies from 1 to 20 nm, depending on the stability of the
sample.
Both SEM and TEM are electron microscopy techniques in which electrons are
bombarded on the sample to obtain morphological information. While TEM provides
information in the nanometer range (100-200 nm), its use can be limited to more stable
fibrils that do not disintegrate due to the high voltage used (100-200 kV). On the other
hand, FESEM can be used to image relatively unstable biomolecules since it uses lower
acceleration voltage (1-10 kV).
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Figure 2.9 Schematic of the working principle of scanning electron microscope.
Adapted from Scanning Electron Microscopy and X-ray Microanalysis. Third
Edition Goldstein, J., Newbury, D.E., Joy, D.C., Lyman, C.E., Echlin, P., Lifshin,
E., Sawyer, L., Michael, J.R.
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2.2.2 Atomic Force Microscopy
Atomic Force Microscopy (AFM) was invented by Binnig et.al. in 1986 and has been
used since then to study molecular interactions, mechanical forces and surface
topography11. It uses a force-sensing cantilever and has a very sharp tip that scans over
the sample surface. As the distance between tip and surface decreases, the close-range
attractive force between the surface and the tip causes the cantilever to deflect towards
the sample. However, as the distance decreases significantly and the cantilever tip
comes in contact with the sample surface, repulsive forces become dominant, causing
the cantilever to deflect away from the sample. A typical schematic of AFM is shown
in Figure 2.10.
The tip of the cantilever scans through the sample surface and the tip-surface interaction
is monitored by the deflection of the laser beam on the cantilever. This deflection is
measured by a position sensitive quadrant photo diode and information is transferred
to the computer. The tip rasters along x and y direction and the force between the
surface and tip along z direction is measured as a function of x and y13.
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Figure 2.10 Schematic drawing of AFM apparatus. The set up consists of a sharp tip
integrated into the apex of a micro-fabricated cantilever spring, a solid substrate surface
(piezo scanner) to support the sample, an optical beam apparatus to detect the
cantilever’s deflection, and an electronic system to record and analyze data. Adapted
from Barattin R. et al. (2008) Chem. Comm. 1513-1532

AFM uses two modes to investigate the sample surface – contact mode and tapping
mode. In contact mode, the tip remains in contact with the sample and is very sensitive
even to the slightest of changes in the sample topography. Tapping mode is a dynamic
mode where the tip oscillates close to its resonance frequency and scans the sample
surface. The contact between the tip and surface during tapping results in the reduction
of the cantilever vibration amplitude. In both contact and tapping mode, the deflections
caused by the tip-sample interaction are measured by laser deflection13.

55

New generation AFM allows sample imaging under ambient conditions as well as
within aqueous solutions at physiological conditions. This has greatly improved its
usage for imaging biomolecules. Either contact or tapping mode can be used for
biomolecular imaging with pros and cons for both. Contact mode provides higher
resolution images, although the sample needs to be immobilized on a surface in order
to avoid deformation or damage. Immobilization can be a tedious process thereby
limiting the use of contact mode. Tapping mode reduces sample deformation and
damage, thus providing better accuracy14, 15.

2.3 Cell Based Assays
Cell based assays are mainly used to screen drug compounds by quantifying their effect
on cell viability and proliferation. These assays are widely used to monitor organelle
functioning and to measure receptor binding and signal transduction. In order to
understand the mechanism of protein aggregation and the toxicity of aggregates with
diverse morphology, it is important to study the effect of these aggregates on cells.
A variety of cell based assays are available that measure an aspect of metabolism or
enzymatic activity of viable cells. Dead cells are unable out carry to cellular function,
and hence can be differentiated from live cells. These assays require incubating viable
cells with a reagent that converts the substrate to a colored fluorescent product. The
product is detected using a plate reader. The absorbance signal of the product at 490
nm is roughly proportional to the amount of viable cells present14.
Tetrazolium salt based reduction assays are most commonly used. Until recently, the
most

commonly

used

compound

was
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(3-(4,5-dimethylthiazol-2-yl)-2,5-

diphenyltetrazolium bromide) (MTT). It is a positively charged compound that
penetrates into viable cells. MTT was later developed into (3-(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), which is a
negatively charged compound that does not readily penetrate into cells. The mechanism
of identifying viable cells using MTS reagent is shown in Figure 2.11. It involves an
intermediate electron acceptor that can transfer electrons from the plasma membrane
or cytoplasm, in order to facilitate the reduction of tetrazolium salt and formation of
colored formazan product via mitochondrial succinate dehydrogenase enzyme16, 17.

MTS reagent has an advantage over MTT because it is directly soluble in cell culture
medium. This eliminates a liquid handling step of adding a second reagent to solubilize
the formazan precipitates. MTS reagent uses an intermediate electron acceptor such as
phenazine methyl sulfate (PMS) or phenazine ethyl sulfate (PES) that can penetrate
viable cells. These get reduced in the cytoplasm or cell surface and exit the cells where
they are converted into soluble formazan products.
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Figure 2.11 Reaction mechanism of MTS Assay. Intermediate electron acceptor
phenazine ethyl sulfate (PES) transfers electron from NADH in the cytoplasm to reduce
MTS in the culture medium into an aqueous soluble formazan.

2.4 Polyacrylamide Gel Electrophoresis
Polyacrylamide gel electrophoresis (PAGE) is a versatile technique to separate
macromolecules like proteins based on their molecular weight, conformation and net
charge. The electrophoretic mobility of a protein is directly proportional to voltage and
charge on the molecule and inversely proportional to the molecular weight,
hydrodynamic radius, shape and size. A typical gel-electrophoresis set up is shown in
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figure 2.12. Polyacrylamide gel is formed by the polymerization of acrylamide
crosslinked by N,N’-methylene-bis-acrylamide (BIS). The polymerization reaction is
initiated by ammonium persulfate (APS) and catalyst –N,N,N’N’-tetramethylene
diamine (TEMED). The concentration of acrylamide and BIS can be varied to obtain a
median pore size between 0.5 and 3 nm. Additionally, anionic detergent sodium
dodecyl sulfate (SDS) is also added. It denatures and binds to the protein and provides
a uniform net negative charge to the protein. This allows separating proteins based only
on their molecular weight and is known as SDS-PAGE. This type of electrophoresis
also involves denaturing the protein by heating it in a buffer containing thiol-modifying
agent 2-mercaptoethanol (β-ME). β-ME reduces the disulfide bonds in the protein to
free sulfhydryl groups and SDS disrupts all the inter- and intra-molecular interactions.

59

Figure 2.12 A typical polyacrylamide gel electrophoresis apparatus set up. Protein
samples are loaded in the wells and they migrate from cathode (-) to anode (+) on
application of electric field1. From: Lehninger Principles of Biochemistry 6E, by David
L. Nelson and Michael M. Cox, Copyright 2013, by W.H. Freeman and Company.
Used by permission of the publisher.
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A modification of SDS PAGE is a non-reducing SDS PAGE where already reduced
disulfide bonds are prevented from re-forming by blocking the free sulfhydryls by
iodoacetamide. After blocking, samples are mixed with buffer containing SDS sample
buffer (without β-mercaptoethanol). This is important the protein already has reduced
disulfide bonds and maintaining them is key for the investigation.
In an alternate form of PAGE, SDS is not added and the protein is resolved on the gel
based on its molecular weight as well hydrodynamic radius. This is known as Native
PAGE since the protein samples are prepared in a non-reducing, non-denaturing buffer
that helps in maintaining the secondary structure and shape of the protein.
Typical gels used for protein separation are discontinuous gels. These are constructed
with two difference acrylamide gels on top of one another. The upper gel (stacking gel)
is a loose gel with 4-5% acrylamide content. The lower gel is resolving gel with a higher
acrylamide content (8%-20%). Stacking and resolving gel are maintained at different
pH and this discontinuity leads to a current discontinuity as voltage is applied. The
combination of stacking and resolving gels increase the resolution of protein separation
by concentrating the sample to an ultrathin zone at the boundary of stacking and
resolving gel. The protein is mixed with running buffer that contains glycerol. High
density of glycerol ensures that the samples remain within the “well” in the gel. The
top of the apparatus forms the cathode whereas bottom forms the anode. When voltage
is applied, proteins migrate downward to the positively charged electrode due the net
negative charge on the protein (in case of SDS PAGE). In case of native PAGE,
(protein’s net charge depends on content of acidic and basic amino acid) most proteins
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that have isoelectric point (pI) in the 3-8 range migrate towards the positive electrode.
If the protein of interest has a pI greater than 8, then native PAGE can be effectively
performed by reversing the electrode polarity. The stacking gel has low ionic strength
that increases the electrical resistance allowing the protein to migrate faster in the
running gel18, 19.
In all gels, a tracking dye called bromophenol blue (BPB) is used to determine the
electrophoresis time where BPB serves as a visual indicator. BPB is a small molecule
that migrates faster than the proteins and can be used effectively without losing proteins
in the process.

2.5 Mass Assisted Laser Desorption/Ionization (Time-of-Flight) Mass
Spectrometry
The main principle of mass spectrometry (MS) is to produce, separate and detect gasphase ions. Sample to be analyzed by this method needs to ionize to produce gas-phase
ions. Traditionally, samples were ionized using electron impact or chemical ionization
methods. However, these methods were not suitable for handling biomolecules since
they fragment and degrade the molecules significantly during the ionization process.
This called for development of ‘soft’ ionization techniques such as Mass Assisted Laser
Desorption/Ionization (Time-of-Flight) Mass Spectrometry (MALDI-MS) for analysis
of biomolecules20 as shown in figure 2.13
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Figure 2.13 Typical set up of MALDI-TOF Mass Spectrometer. Analyte
(biomolecules) is mixed with matrix and the co-crystals are allowed to form on the
target and loaded into a vacuum chamber. Analyte molecules are desorbed by high
energy radiation and accelerated through electric field causing the analyte ions to fly to
the detector where the mass to charge ratio is obtained as the mass spectrum output.
Adapted from Kim,S. et al. (2003) Nat. Rev. Genetics 4, 1001-1008.
MALDI involves the use of a small crystalline organic compound (matrix) in which
the sample of interest in embedded. The mix of sample and matrix is deposited on a
conductive sample support (target). The matrix and sample co-crystals are irradiated
with a nanosecond UV laser beam with a wavelength of 226 or 337 nm. This contributes
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to an energy range between 1x107 and 5x107 W/cm2. This energy decomposes the cocrystals and creates a particle cloud from which ions are extracted by an electric field.
The ions in gas-phase are accelerated through the electric field followed by a drift in a
field-free path and finally reaches the detector. This desorption process is mainly
understood as the conversion of laser energy to vibrational collision energy of the
crystal molecules, leading to disintegration of the crystal molecules. A variety of mass
analyzers are available to study biomolecules such as proteins. These range from
hybrid-quadrupole time-of-flight (Q-Q-ToF) and tandem time-of-flight (ToF-ToF).
MALDI provides information in the form of mass to charge ratios (m/z) that is
calculated by measuring the typical time-of-flight (TOF) through a tube of specified
length in vacuum20-22. TOF is longer for larger molecules provided their initial energies
are identical. MALDI predominantly generates single charged, non-fragmented ions,
hence making data processing less complicated.
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Abstract
Insulin aggregates under storage conditions via disulfide interchange reaction. It is
also known to form aggregates at the site of repeated injections in diabetes patients,
leading to injection amyloidosis. This has fueled research in pharmaceutical and
biotechnology industry as well as in academia to understand factors that modulate
insulin stability and aggregation. The main aim of this study is to understand the
factors that modulate aggregation propensity of insulin under storage conditions.
We explored the aggregation kinetics of insulin at pH 7.2 and 37 °C in the presence
of disulfide-reducing agent dithiothreitol (DTT), using spectroscopy (UV-visible,
fluorescence, and Fourier transform infrared spectroscopy) and microscopy
(scanning electron microscopy, atomic force microscopy) techniques. We prepared
insulin ‘seeds’ by incubating disulfide-reduced insulin at pH 7.2 and 37 °C for
varying lengths of time (10 min to 12 h). These seeds were added to the native
protein and nucleation-dependent aggregation kinetics was measured. Aggregation
kinetics was fastest in the presence of 10 min seeds suggesting they were nascent.
Interestingly, intermediate seeds (30 min to 4 h incubation) resulted in formation
of transient fibrils in 4 h that converted to amorphous aggregates upon longer
incubation of 24 h. Overall, the results show that insulin under disulfide reducing
conditions at pH and temperature close to physiological favors amorphous
aggregate formation and seed ‘maturity’ plays an important role in nucleation
dependent aggregation kinetics.
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Introduction
More than 29 million people have diabetes in USA alone and this number is on the rise
with more than one million new cases of diabetes diagnosed every year1. Nearly 14%
of these patients take insulin, a globular hormone that has been used as treatment of
insulin-dependent diabetes for more than seven decades1. Studies in the last two
decades show that insulin plays an important role in cognition and memory. Insulin is
also known to regulate metabolism of beta-amyloid peptide and phosphorylation of tauprotein that is robustly linked to Alzheimer’s disease2. Even though, insulin has been
used for diabetes for several decades, its high cost due to poor stability and ease of
forming aggregates when stored is a major challenge for the pharmaceutical industry.
Insulin undergoes self-association by disulfide interchange reaction and aggregates
under storage conditions3, 4. Previous works show that insulin tends to precipitate when
reacted with a disulfide interchange enzyme in presence of reducing agent. This
aggregation was attributed to scrambling of disulfide bonds5, 6. In addition, insulin can
also aggregate at the site of injection in the subcutaneous tissue which has a pH of
~7.27, 8. Even though, several insulin aggregation studies have been carried out at
neutral pH either at high temperature or in the presence of chaotropic agents (e.g. urea
or guanidine hydrochloride)9, 10, very few studies have explored insulin aggregation
under conditions close to physiological11-13. Therefore, it is important to understand the
factors that govern insulin stability and aggregation at neutral pH at which insulin is
generally stored. Understanding the mechanism of insulin denaturation and aggregation
during storage conditions will help in formulating effective solutions to increase the
shelf life of the protein and prevent injection amyloidosis.
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Insulin consists of two polypeptide chains: a 21-residue A-chain and a 30-residue Bchain. It has 3 disulfide bridges that stabilize the protein structure; two inter-chain
disulfide bonds (A7-B7, A20-B19) and one intra-A-chain (A6-A11) disulfide bond14,15.
At acidic conditions, insulin is predominantly a monomer and the hexamer prevails at
neutral pH16 (Figure 3.1). Insulin fibrils have been reported in case of human
insulinoma as well as in pancreatic tumors17. Classically, the aggregation propensity of
this protein has been studied at acidic pH and elevated temperatures18-21. Under these
conditions, it has been shown to form fibrils that exhibit characteristic amyloid
properties that are assumed to start from partially unfolded monomeric intermediates22,
23

. Changes in pH, ionic strength, anions, and stabilizers affect the lag time and fibril

growth formation in insulin suggesting the importance of hydrophobic and electrostatic
interactions during initial aggregation process13. Studies involving solvation effects on
insulin fibrillation exhibited aggregation in the presence of ethanol and
trifluoroethanol22. All these studies point towards a general hypothesis that any external
perturbation contributes towards insulin aggregation18, 20, 23-27.
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Figure 3.1 Ribbon structure of insulin hexamer at neutral pH. Firebrick red sticks are
used to denote the disulfide bonds (-S-S-) between A7-B7, A20-B19 and A6-A11
positions in each monomer. The backbone is shown in gray color. The structures were
generated using PyMOL 1.3 and PDB file 1AI029.

Liquid insulin formulations prepared for diabetics, come with an expiration time span
of 18-24 months. This long-term storage of insulin can lead to instability of the protein
resulting in formation of unwanted products and possible complications such as
injection amyloidosis when administered to patients14. One of the major causes of loss
of native protein structure and aggregation is loss of critical S-S bonds or formation of
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scrambled disulfide bonds that destabilize the protein structure 26, 27. Previous studies
on insulin with reduced and alkylated disulfide bonds showed increased aggregation
rate when compared to insulin with intact disulfide bonds27, 28. This underscores the
importance of disulfide bonds in the overall stability and activity of the protein.
Therefore, it is important to study how reducing environment near physiological pH
can affect protein stability and hence modulate its aggregation over a period of time. In
this study we show reduction of disulfide bonds of insulin leads to rapid aggregation
within 10 min. Interestingly, we did not observe any fibrillar aggregates under these
conditions. Instead, we observed amorphous insulin aggregates that stayed amorphous
even after 6 months of incubation time. AFM images of native insulin in the presence
of 30 min to 1 h insulin seeds show fibrillar aggregates after 4 h of incubation that
converts to amorphous aggregates upon incubation for 24 h. Native insulin incubated
with 10 min seeds form amorphous aggregates only. This study provides a mechanistic
insight into insulin instability and how seeds from different stages of protein
aggregation can affect native protein’s aggregation kinetics and the nature of
aggregates. This may help us better understand nucleation dependent aggregation
process at the molecular level for improperly stored insulin and injection amyloidosis
in diabetes patients.
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Materials and Methods
Unless otherwise indicated, all materials were used as supplied by the manufacturer
without any further purification. Human recombinant insulin, dithiothreitol (DTT),
thioflavin T (ThT), 8-anilino-1-naphthalenesulfonic acid (ANS) dye, 4,4′-Dianilino1,1′-binaphthyl-5,5′- disulfonic acid (bis-ANS) dye were purchased from Sigma.
Preparation of insulin samples - Insulin was dissolved in 0.025 M HCl at a
concentration of 10 mg/mL. The protein was allowed to equilibrate overnight at 4 oC
with mild agitation. To the insulin solution 0.025 M NaOH was added to neutralize the
HCl. Then, insulin aliquots were made to the final concentration of 1 mg/mL (unless
otherwise indicated) in 20 mM sodium phosphate buffer at pH 7.2 having 150 mM
NaCl. All samples were prepared either in presence or absence of 10 mM dithiothreitol
(DTT). The samples were prepared on ice followed by incubation at 37 oC for the
indicated time periods (see figures for details). Blanks (contained everything except
protein) were similarly prepared and incubated as samples and were used for
background subtraction.
Seeding activity of disulfide-reduced insulin aggregates – Insulin seeds were prepared
by incubating 1 mg/mL (172 µM) insulin in presence of 10 mM DTT in phosphate
buffer, for 10 min, 30 min to 4 h (30 min intervals), and 4 h to 12 h ( 1 h intervals) at
37oC. Post incubation, seeds were washed with distilled water using Millipore
Amicon® Ultra centrifugal filters (3000 Da cutoff) and were added to freshly prepared
native insulin sample (all disulfide bonds intact) at a concentration of 5%, 15% and
45% v/v. Negative controls were prepared using identical conditions as samples but in
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the absence of seeds. All samples were prepared on ice and then incubated at 37 oC for
the indicated time. In addition to incubating insulin at 1 mg/mL (172 µM), samples
were also diluted to a final protein concentration of 90 µM and 20 µM in phosphate
buffer to study the effect of dilution on aggregation kinetics. All measurements were
done in triplicates at 25 oC.
Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry
(MALDI-TOF MS) – Microflex LRF MALDI-TOF mass spectrometer (Bruker)
equipped with microScout Ion Source was used to characterize disulfide states in the
insulin samples. Insulin was incubated with 10 mM DTT for 0, 15 min, and 4 h at 37
o

C. Fresh native insulin was used as control. Post incubation, samples (and control)

were incubated with freshly prepared 100 mM iodoacetamide (IAA) for 2 h at room
temperature to block the free sulfhydryl groups. Low molecular weight contaminants
were removed using C18 ZipTip®. Samples were prepared on the target using the direct
droplet method. In this method, a saturated matrix solution of α-Cyano-4Hydroxycinnamic acid was mixed with solvent (0.1% trifluoroacetic acid (TFA) with
33% acetonitrile (ACN)) having sample in 1:1 ratio v/v (matrix:solvent). From this
mixture 1μL of sample was aliquoted and dried at room temperature on the target before
analyzing.
UV-visible absorbance spectroscopy- Absorbance measurements were performed
using a Perkin Elmer Lambda 35 UV-visible Spectrophotometer. After completion of
incubation, absorbance of samples was measured at 600 nm in order to assess turbidity
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of insulin samples due to aggregation. All measurements were done at room
temperature and in triplicates.
Intrinsic and extrinsic fluorescence- Fluorescence measurements were carried out
using a Horiba Jobin Yvon spectrofluorometer (Fluoromax-4). Excitation and emission
slit widths were set at 2 nm, each. For intrinsic fluorescence, emission spectra were
acquired from 285 to 450 nm with excitation at 280 nm. For extrinsic fluorescence,
emission spectra were acquired in presence of 10 µM ThT, 10 µM ANS, or 1 µM bisANS. The concentrations of dye stocks were determined using their extinction
coefficients: ANS ε350 nm = 5000 M-1 cm-1, bis-ANS ε385 nm = 16790 M-1 cm-1, and ThT
ε416

nm

= 26,620 M-1 cm-1. Protein samples were equilibrated with respective

fluorophores on ice, in dark for 30 min before acquiring the spectra. For ThT
fluorescence, emission spectra were collected from 460 to 650 nm with excitation at
450 nm. Fluorescence spectra from 400 to 700 nm were collected with excitation at
380 nm for ANS and at 360 nm for bis-ANS. All measurements were done in triplicates.
Field Emission Scanning Electron Microscopy (FESEM) – Electron microscope
images were collected using Hitachi S-4700 field-emission scanning electron
microscope (FESEM). Samples incubated for indicated times were diluted with doubledistilled water and aliquoted in Millipore Amicon® Ultra centrifugal filters (3000 Da
cut off). The diluted samples were centrifuged at 7000 x g at 4 oC (three repeats after
dilution with water) to remove low molecular weight impurities (salt, buffer etc). The
washed samples were aliquoted on SEM stubs and air-dried. The samples were
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platinum coated using a sputter coater and imaged using an acceleration voltage of 10
kV.
Atomic Force Microscopy (AFM) – Aggregates of insulin were analyzed by aliquoting
7 uL of sample on a freshly cleaved mica surface at 25 oC. AFM imaging was
performed on Dimension ICON AFM system (Bruker, CA, USA) using Peakforce
Tapping mode. Scan-Asyst-Air cantilevers (Bruker, CA, USA) with spring constant
0.4 N/m and resonant frequency 70 kHz were selected as recommended by the
manufacturer. AFM image analysis was carried out using NanoScope Analysis
software from Bruker, CA, USA.
Nano-mechanical measurements were performed using Dimension ICON AFM
(Bruker, USA) under ambient conditions using Peakforce Tapping mode. RTESPA
cantilevers (Bruker, USA) were selected with calibrated spring constant and tip radius
of 55.6 N/m and 12 nm, respectively. For nano-mechanical measurements, 1 mg/mL
insulin was incubated with 45% v/v seeds (10 min, 30 min, 1 h, 4 h) for 4 hours.
Samples were prepared on freshly cleaved mica similar to AFM imaging. DerjaguinMueller-Toporov (DMT) modulus analysis was carried out using NanoScope software
from Bruker, CA, USA. The Young’s modulus value for each sample was calculated
by averaging the moduli of each aggregate in a sample using the Nanoscope software.
Fourier

Transform-Infrared

Spectroscopy

(FT-IR)

–

Secondary

structure

determination of insulin seeds were performed using Perkin Elmer Frontier FT-IR
spectrometer. Seeds were prepared by incubating 1 mg/mL insulin with 10 mM DTT
at 37 oC for 10 min, 30 min, 1 h and 4 h followed by washing as discussed earlier. A
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drop of sample was placed on the crystal and allowed to dry at room temperature. Data
was acquired at a resolution of 4 cm-1 and 128 scans were averaged per sample. Data
was analyzed between 1800 and 1600 cm-1 after subtracting the background. Raw
spectra were deconvoluted using Gaussian model to obtain the component peaks and
the contribution from each peaks was calculated by integrating area under the curves
using Origin 9.1.

Results
In this work, we monitored aggregation of insulin (Figure 3.1) in presence and absence
of 10 mM DTT at pH 7.2 and at 37 oC. We also measured the aggregation kinetics of
native insulin in presence of “seeds” prepared by incubating disulfide-reduced insulin
(insulin incubated with 10 mM DTT) for different time periods (10 min to 12 h). The
kinetics, morphology, and secondary structure of the aggregates were studied using a
variety of biophysical and analytical methods. Susceptibility of insulin to disulfide
bond reduction was investigated using MALDI-TOF (Figure 3.2). Samples incubated
for 15 min and 4 h with 10 mM DTT (Figure 3.2C, 3.2D) had the highest proportion of
Insulin B-chain (3.5 kDa) along with dimers of full-length protein as well as B-chain
(11.6 and 7.1 kDa respectively). Aggregated forms of B-chain dimer along with Achain were also observed at a molecular mass of 9.6 kDa. Trace amounts of A-chain
(2.5 kDa) and insulin monomer were also visible. Fresh insulin in the absence or
presence of reducing agent predominantly showed the existence of intact insulin
(Figure 3.2A, 3.2B). However, in the presence of 10 mM DTT, the inter-chain disulfide
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bonds in insulin were cleaved rapidly showing increase in B chain content (Figure 3.2C,
3.2D).
The extent of protein aggregation was monitored by measuring the turbidity (optical
density (O.D.)) at 600 nm, using a UV-visible spectrophotometer (Figure 3.3). The
absorbance of samples containing 10 mM DTT increased with increasing incubation
time but was mostly unchanged for the control groups (proteins not treated with
reducing agent). Significant increase in O.D. was observed within the first 1 h of
incubation.
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Figure 3.2 Mass spectrometry (MALDI-TOF) analysis showing effect of 10 mM DTT
on disulfide status of insulin. Insulin was incubated with 10 mM DTT for 0 min, 15
min, and 4 h at 37 °C. Fresh insulin was used as control. Post incubation, samples (and
control) were alkylated with 100 mM IAA for 2 h before running on MALDI-TOF.
Fresh insulin in the presence and absence of reducing agents were similarly alkylated
using IAA and were run as controls.
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Figure 3.3 Protein aggregation monitored by UV absorbance. Insulin was incubated at
37o C for the indicated time periods and UV absorbance of the samples were measured
at 600 nm. Error bars indicate ± SD.

Insulin misfolding, conformational change, hydrophobic exposure, and aggregation
were monitored by intrinsic and extrinsic fluorescence. Protein misfolding and
conformational change for disulfide-reduced insulin was investigated by measuring the
change in intrinsic fluorescence (Figure 3.4). We used extrinsic fluorophores such as
8-anilino-1-naphthalenesulfonic acid (ANS), to measure misfolding and extent of
hydrophobic exposure; and 4,4′-Dianilino-1,1′-binaphthyl-5,5′- disulfonic acid (bisANS) as a conformational tightening agent and measure of hydrophobic exposure
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(Figure 3.5). Thioflavin T (ThT) was used to monitor the nature of aggregates (Figures
3.8). The morphology (Figure 3.9 to 3.11, 3.21. 3.22) and secondary structure (Figure
3.28) of the aggregates were further characterized by microscopy techniques (SEM,
AFM) and FT-IR respectively.
Insulin samples incubated with 10 mM DTT show a rapid decline in fluorescence as a
function of time, whereas no measurable change in fluorescence intensity was observed
for the protein in the control groups (0 M DTT). The steepest drop in fluorescence
intensity for DTT treated samples is observed in the first 20 min (inset in Figure 3.4).
Fluorescence intensity continues to decrease rapidly up to 48 h and then slows down
and the intensity stabilizes. Misfolding and hydrophobic exposure of insulin was
monitored using ANS and bis-ANS (Figure 3.5). Both ANS and bis-ANS show a rapid
increase in fluorescence intensity in the first 20 min and then was steady beyond 1 h of
incubation time. Control samples (samples with no DTT) did not show any change in
fluorescence upon addition of the dyes.
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Figure 3.4 Insulin unfolding monitored by intrinsic fluorescence. Fluorescence spectra
for 172 μM insulin incubated with/without 10 mM DTT were collected from 285 to
450 nm with excitation at 280 nm. Peak emission wavelength of 306 nm was selected.
Peak fluorescence intensities are shown using open symbols (without DTT) and closed
symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation. Error
bars indicate ± SD.
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Figure 3.5 Protein misfolding and hydrophobic exposure monitored by ANS and bisANS fluorescence. Insulin samples at 172 μM concentration were incubated with 10
µM ANS or 1 µM bis-ANS for 15 min before acquiring spectra. Emission spectra were
collected from 400 to 700 nm with excitation at 380 nm for (A) ANS and 360 nm for
(B) bis-ANS. Average peak emission wavelengths of 467 nm and 482 nm were selected
for ANS and bis-ANS, respectively. Peak fluorescence intensities are shown using open
symbols (without DTT) and closed symbols (with 10 mM DTT). Inset shows a plot for
the first 1 h of incubation. Error bars indicate ± SD.
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Figure 3.6 ANS fluorescence peak intensity and wavelength shift as a function of time.
Insulin samples at 172 μM protein concentration were incubated with 10 μM ANS, and
emission spectra were acquired as detailed in figure 4. Peak fluorescence intensities are
shown in black and wavelength for peak maxima are in red. Error bars indicate ± SD.
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Figure 3.7 ANS fluorescence emission spectra, peak intensity wavelength, and
wavelength shifts as a function of time. Insulin samples at 172 μM protein
concentration were incubated with 10 mM DTT and then were diluted with phosphate
buffer (20 mM, pH 7.2) to a final concentration of 20 μM and 90 uM before analysis.
Protein samples were incubated with 10 μM ANS and emission spectra was acquired
for (A) 20 μM and (C) 90 μM insulin as detailed in figure 4. Wavelength shifts were
plotted for (B) 20 μM and (D) 90 μM protein. Fluorescence intensities are shown in
black and wavelength for peak maxima are in red. For emission spectra, peak
fluorescence intensities are shown using open symbols (without DTT) and closed
symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation. Error
bars indicate ± SD.
The nature and morphology of the aggregates were further characterized by ThT
fluorescence, SEM and AFM imaging. ThT is known to bind to amyloid fibrils as well
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as large aggregates and fluoresces30, 31. Fluorescence intensity for DTT treated insulin
increased rapidly in the first 30 min of incubation, followed by a gradual increase upon
longer incubation (Figure 3.8). Whereas, insulin incubated similarly but in absence of
DTT (control groups) did not show any change in fluorescence intensity over the length
of time. SEM images of insulin samples treated with DTT and incubated at 37 °C for
different time periods (15 min, 2 h, 4 h, 168 h, or 6 months) were taken (Figures 3.9,
3.10, and 3.11). Freshly incubated insulin samples with and without DTT were imaged
as controls (Figure 3.10, panels A and B). All the aggregates were amorphous in nature
with an average subunit diameter of 200 ± 100 nm (Figure 3.9)32. The morphology of
aggregates remained unaltered even after a prolonged incubation of 6 months (Figure
3.11).
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Figure 3.8 Protein aggregation monitored by ThT fluorescence. Emission spectra for
57 μM insulin in the presence of 10 μM ThT were acquired from 460 to 650 nm with
excitation at 450 nm. Average emission peak wavelength of 486 nm was selected. Peak
fluorescence intensities are shown using open symbols (without DTT) and closed
symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation. Error
bars indicate ± SD.
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Figure 3.9 Scanning electron microscope images of insulin aggregates. Aggregates of
insulin were imaged using SEM. Insulin samples were incubated at 37 °C with 10 mM
DTT for (A) 15 min, (B) 2 h, (C) 4 h, and (D) 168 h, respectively. Scale bar for all
panels is 500 nm.
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Figure 3.10 Scanning electron microscope images of insulin aggregates incubated for
different times. Insulin aggregates were made by incubating 172 uM insulin in the
absence (A) and presence (B-F) of 10 mM DTT at 37 oC, at pH 7.2. Insulin images are
(A) 0 h (no DTT) and samples incubated with 10 mM DTT for (B) 0 h (C) 15 min (D)
2 h, (E) 4 h and (F) 168 h, respectively. Scale bars are 50 μm, 10 μm, 5 μm and 500 nm
from left to right.
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Figure 3.11 Insulin samples incubated for 6 months show amorphous aggregates.
Insulin was incubated at 37o C in presence of 10 mM DTT for 6 months before imaging
the aggregates with SEM at indicated magnifications. Scale bars are shown in each
panel.

The effect of electrostatic interaction on insulin aggregation was studied in the absence
as well as presence (150 or 300 mM) of NaCl. In addition, insulin concentration was
also varied (20, 90, or 172 μM) (Figures 3.12 to 3.17). Increasing the salt concentration
up to 300 mM did not alter the overall aggregation kinetics (Figures 3.12 to 3.17).
Furthermore, change in insulin concentration (20, 90, or 172 μM) did not affect the
overall trend for the fluorescence.
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Figure 3.12 Effect of electrostatic interactions on insulin misfolding monitored by
intrinsic fluorescence over time. Intrinsic fluorescence spectra were collected from 285
to 450 nm with excitation at 280 nm. Peak emission wavelength of 306 nm was
selected. Insulin samples at 172 μM protein concentration were incubated in the
absence or presence of NaCl. Peak fluorescence intensities are shown using open
symbols (without DTT) and closed symbols (with 10 mM DTT). Inset shows a plot for
the first 1 h of incubation. Error bars indicate ± SD.
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Figure 3.13 Effect of electrostatic interactions on insulin misfolding monitored by
intrinsic fluorescence over time. Intrinsic fluorescence spectra were collected from 285
to 450 nm with excitation at 280 nm. Peak emission wavelength of 306 nm was
selected. Insulin samples at 172 μM protein concentration were incubated in the
absence or presence of NaCl and spectra were acquired at a final concentration of (A)
90 μM and (B) 20 μM. Peak fluorescence intensities are shown using open symbols
(without DTT) and closed symbols (with 10 mM DTT). Inset shows a plot for the first
1 h of incubation. Error bars indicate ± SD.
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Figure 3.14 Effect of electrostatic interactions on hydrophobic exposure monitored by
Bis-ANS fluorescence over time. Fluorescence spectra were collected from 400 to 700
nm with excitation at 360 nm. Peak emission wavelength of 482 nm was selected.
Insulin samples at 172 μM protein concentration were incubated in the absence or
presence of NaCl. Peak fluorescence intensities are shown using open symbols (without
DTT) and closed symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of
incubation. Error bars indicate ± SD.
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Figure 3.15 Effect of electrostatic interactions on hydrophobic exposure monitored by
Bis-ANS fluorescence over time. Fluorescence spectra were collected from 400 to 700
nm with excitation at 360 nm. Peak emission wavelength of 482 nm was selected.
Insulin samples at 172 μM protein concentration were incubated in the absence or
presence of NaCl and spectra were acquired at a final concentration of (A) 90 μM and
(B) 20 μM. Peak fluorescence intensities are shown using open symbols (without DTT)
and closed symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of
incubation. Error bars indicate ± SD.
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Figure 3.16 Effect of electrostatic interactions on insulin aggregation monitored by
ThT fluorescence over time. Fluorescence spectra were collected from 460 to 650 nm
with excitation at 450 nm. Peak emission wavelength of 486 nm was selected. Insulin
samples at 172 μM protein concentration were incubated in the absence or presence of
NaCl. Peak fluorescence intensities are shown using open symbols (without DTT) and
closed symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation.
Error bars indicate ± SD.
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Figure 3.17 Effect of electrostatic interactions on insulin aggregation monitored by
ThT fluorescence over time. Fluorescence spectra were collected from 460 to 650 nm
with excitation at 450 nm. Peak emission wavelength of 486 nm was selected. Insulin
samples at 172 μM protein concentration were incubated in the absence or presence of
NaCl and spectra were acquired at a final concentration of (A) 90 μM and (B) 20 μM.
Peak fluorescence intensities are shown using open symbols (without DTT) and closed
symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation. Error
bars indicate ± SD.
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Seeding experiments were carried out by incubating native insulin with seeds for
varying lengths of time at 37 °C. Seeds were prepared by incubating disulfide-reduced
insulin at pH 7.2 at 37 °C for 10 min, 30 min to 4 h (30 min intervals) and 5 h to 12 h
(1 h intervals). Fresh insulin was incubated with 5%, 15% and 45% v/v of various seeds
prepared. The kinetics and morphology of insulin aggregates in presence of seeds were
analyzed by ThT fluorescence and AFM (Figures 3.18 to 3.27, Table 3.1). The
aggregation kinetics of native insulin in the presence of seeds were calculated by fitting
the ThT fluorescence data at 45% v/v seed concentration (Figure 3.23 to 3.25) till 4 h
and the results are shown in Table 3.1. Aggregation of native insulin was fastest in
the presence of 10 min seeds (Figure 3.23, Table 3.1) followed by seeds incubated for
30 min, 1, 1.5 and 4 h (Figure 3.24, Table 3.1). Seeds prepared by incubating insulin
for longer time (5 to 12 h) showed a much slower aggregation kinetics (Figures 3.25,
Table 3.1). Control samples (fresh insulin incubated without seeds) did not show any
change over the experiment period of 7 days. Since, 10 min seeds showed fast and
extreme aggregation efficiency, effect of seed concentrations at 5%, 15% and 45% v/v
by ThT fluorescence on kinetics of native insulin aggregation was measured (Figure
3.27). Seed concentrations alter the aggregation kinetics with 5% seeds showing a
gradual but continuous increase in fluorescence, 15% seeds showing a rapid initial
increase in fluorescence followed by gradual increase in fluorescence, and 45% seeds
showing a very rapid increase in fluorescence intensity that peaks by 4 h of incubation
time and then stabilizes. Insulin aggregates were prepared in the presence of seeds (10
min, 30 min, 1 h and 4h) at a concentration of 45% v/v and were visualized using AFM
with peak force tapping mode in air (Figures 3.21, 3.22). The elastic strength of the
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aggregates along the radial direction (Young’s modulus) was measured using peak
force QNM mode of AFM. This intrinsic stiffness of each aggregate in a sample was
calculated using Nanoscope software and the average number was used to represent the
Young’s moduli of aggregates generated using different timed seeds. The elastic
strength of aggregates formed by incubating native insulin with different timed seeds
(10 min, 30 min, 1 h, and 4 h) were comparable and ranged between 4 ± 0.6 and 6 ±
0.2 GPa. Aggregate population was maximum for protein incubated with 10 min seeds
and it decreased with seed incubation time (Figure 3.21).
Secondary structure of the protein seeds (10 min, 30 min, 1 h and 4 h) were analyzed
using FT-IR (Figure 3.28) in the amide I band region (1700-1600 cm-1). The raw
spectra were deconvoluted using Gaussian model to obtain the component peaks.
Native insulin showed a peak at 1656 cm-1 whereas seeds exhibited peaks at 1656 cm1

and 1625 cm-1 upon deconvolution. Area under the peaks was integrated to obtain the

relative contribution of component peaks at 1656 cm-1 and 1625 cm-1, respectively.
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Figure 3.18 Effect of seeding (by different time seeds) on native protein aggregation
monitored by ThT fluorescence. Seeding concentration used for all experiments was
5% seed v/v. Seeds were prepared by incubating 172 uM insulin for 10, 30 min, 1 or 4
h, in presence of 10 mM DTT. The spectra were acquired at (A) 172 μM protein
concentration and also after dilution of protein to (B) 90 μM and (C) 20 μM
concentrations. ThT fluorescence experiments were performed as detailed in Figure
3.8. Error bars indicate ± SD.
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Figure 3.19 Effect of seeding (by different time seeds) on native protein aggregation
monitored by ThT fluorescence. Seeding concentration used for all experiments was
15% seed v/v. Seeds were prepared by incubating 172 uM insulin for 10, 30 min, 1 or
4 h, in presence of 10 mM DTT. The spectra were acquired at (A) 172 μM protein
concentration and also after dilution of protein to (B) 90 μM and (C) 20 μM
concentrations. ThT fluorescence experiments were performed as detailed in Figure
3.8. Error bars indicate ± SD.
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Figure 3.20 Effect of seeding (by different time seeds) on native protein aggregation
monitored by ThT fluorescence. Seeding concentration used for all experiments was
45% seed v/v. Seeds were prepared by incubating 172 uM insulin for 10, 30 min, 1 or
4 h, in presence of 10 mM DTT. The spectra were acquired at (A) 172 μM protein
concentration and also after dilution of protein to (B) 90 μM and (C) 20 μM
concentrations. ThT fluorescence experiments were performed as detailed in Figure
3.8. Error bars indicate ± SD.
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Figure 3.21 AFM Images of insulin aggregates after incubating with different timed
seeds for 4 h. Insulin samples at 172 μM protein concentration were incubated for 4 h
in presence of seeds prepared by incubating for (A) 10 min (nascent seeds) (B) 30 min
(intermediate seeds) (C) 1 h (intermediate seeds) and (D) 4 h (intermediate seeds). For
panel A, B, C, and D the scale bar is 500 nm and the zoomed-in image in panel C is at
100 nm. Arrows indicate proto-fibrillar structures.
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Figure 3.22 AFM images of aggregated insulin after incubating with seeds for 24 h.
Insulin samples at 172 μM protein concentration were incubated for 24 h in presence
of seeds prepared by incubating disulfide-reduced insulin at pH 7.2 and 37 °C for (A)
10 min (B) 30 min (C) 1 h and (D) 4 h. Scale bar is 500 nm.
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Figure 3.23 Linear regression analysis of ThT fluorescence data. ThT fluorescence
plots of native insulin aggregation in the presence of nascent seeds were fitted up to 4
h and kinetics of aggregation was calculated using Origin 9.1
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Figure 3.24 Linear regression analysis of ThT fluorescence data. ThT fluorescence
plots of native insulin aggregation in the presence of intermediate seeds were fitted up
to 4 h and kinetics of aggregation was calculated using Origin 9.1

106

Figure 3.25 Linear regression analysis of ThT fluorescence data. ThT fluorescence
plots of native insulin aggregation in the presence of mature seeds were fitted up to 4
h and kinetics of aggregation was calculated using Origin 9.1
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Figure 3.26 Effect of seed incubation time on native insulin aggregation monitored by
ThT fluorescence. Seeds were prepared by incubating 172 uM insulin for 10 min, 30
min to 4 h (30 min intervals) and 4 h to 12 h (1 h intervals) in presence of 10 mM DTT.
The spectra were acquired as detailed in Figure 3.8. Error bars indicate ± SD.
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Table 3.1 Aggregation kinetics in the presence of seeds incubated from 10 min to 12h.

Seed Incubation Time (h)

Slope after Linear Fit (x103)

0.2

235.92±4.86

0.5

178.18±21.10

1

214.29±29.52

1.5

147.62±5.41

2

84.68±11.65

2.5

78.19±8.20

3

131.11±39.12

3.5

101.87±15.82

4

161.77±41.66

5

114.32±14.71

6

89.17±22.77

7

124.85±75.78

8

35.82±6.06

9

33.11±6.04

10

146.00±42.22

11

130.25±32.00

12

98.37±25.46
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Figure 3.27 Effect of seeding concentration of nascent seeds on aggregation kinetics.
Nascent Seeds prepared by incubating insulin with 10 mM DTT for 10 min were used
at a concentration of 5%, 15% and 45% v/v for seeding experiments. Protein
aggregation was monitored by ThT fluorescence and was performed as detailed in
Figure 3.8.
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Figure 3.28 FT-IR Spectra for the amide I region of insulin aggregates. Aggregates
were prepared by incubating 1 mg/mL insulin with 10 mM DTT for 10 min, 30 min, 1
h and 4 h along with spectra of native protein. (A) Raw FT-IR spectra showing that
amide bands are observed near 1656 and 1625 wavenumbers. (B) Raw FT-IR spectra
(solid lines) and their component peaks (dotted lines) for the seeds.

Discussion
Insulin can easily aggregate due to destabilizing influences and the nature and
morphology of these aggregates are diverse 11, 18, 19, 33-35. Under extremes of conditions
such as pH, temperature, or denaturants, insulin forms beta-sheet rich fibrils

11, 36

.

Several other aggregation studies at physiological pH and temperature in combination
with external perturbations show that proteins can misfold and form a range of
aggregate forms 19, 22, 37. Both amyloid formation and amorphous aggregates have been
reported in the disease process and have been shown to be dependent on external
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factors. In addition, importance of conserved disulfide bond providing stability to
proteins has been explored in several studies

38-40

. It is known that insulin aggregates

at storage conditions by a beta-elimination reaction (scrambled disulfide bonds) and
this may lead to aggregation of insulin at the injection site of diabetes patients leading
to injection amyloidosis. Therefore, to better understand the kinetics and mechanism
of insulin aggregation with compromised disulfide bonds; we studied the effect of
different preformed seeds on the aggregation kinetics of native insulin. In this work,
we used DTT as disulfide reducing agent to accelerate the disulfide scrambling process.
We measured the extent of disulfide reduction using MALDI-TOF mass spectrometry
(Figure 3.2). Fresh insulin sample spectra showed that it was predominantly monomer
(Figure 3.2A, 3.2B). Insulin incubated with 10 mM DTT for 15 min and 4 h show a
significant increase in B-chain monomers (3.5 kDa) with appearance of a new peak at
7.1 kDa that indicates B-chain dimers. Relative abundance peak for insulin monomer
(5.8 kDa) decreased in presence of DTT when incubation time was increased from 15
min to 4 h. (Figure 3.2C, 3.2D). Appearance of a new peak was observed at 9.6 kDa
for insulin incubated with DTT at 15 min and 4 h samples suggesting presence of
aggregated forms of B-chain dimer with A-chain or presence of tetramer of A-chain.
The data suggests cleavage of inter-chain disulfide bonds in insulin at positions A7-B7
and A20-B19 leading to generation of insulin A and B chains. An increase in molecular
weight of ~20-30 Da for the samples could be due to the residual buffer ions present as
contaminants in the sample.
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We monitored aggregation kinetics and secondary structure of insulin at pH 7.2, 37 oC
using various spectroscopic techniques (Figures 3.3 to 3.8) and morphology of
aggregates were characterized by SEM and AFM (Figures 3.9 to 3.11 and 3.21, 3.22).
We investigated effect of 10 mM DTT on insulin instability and aggregation. As
turbidity is a direct measure of the amount of aggregation, the optical density of the
aggregated samples were measured at 600 nm. This method is very useful to detect
aggregates with a hydrodynamic radius greater than the wavelength of light used24, 41.
The aggregation propensity was highest in the first 20 min, after which the process
slowed down considerably. Proteins that were incubated for shorter time periods
showed a very sharp increase in absorbance within the first 10 min, implying rapid
initial aggregation (inset in Figure 3.3). This suggests increased instability and
unfolding of insulin in presences of DTT that leads to misfolding and aggregation of
the protein within 10 min of incubation. Controls similarly incubated in the absence of
DTT did not exhibit any turbidity or increase in absorbance.
Insulin does not have any tryptophan residues therefore intrinsic fluorescence of insulin
was measured by monitoring the exposure of tyrosine (Tyr) residues at 306 nm42,43.
Decrease in fluorescence intensity at 306 nm (Figure 3.4) suggests exposure of Tyr
residues to polar (aqueous) environment leading to fluorescence quenching as a
consequence of protein unfolding44. Fluorescence intensity decreases rapidly in first
20 min followed by a gradual decrease up to 48 h, which is in line with the UV
absorbance data. This suggests that insulin in presence of disulfide reducing agent
unfolds rapidly exposing the hydrophobic core (aromatic residues) followed by
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aggregation. This can be a direct result of catalytic amount of reducing agent promoting
‘disulfide scrambling’ and drastically altering the protein stability21, 25, 26. The effect of
10 mM DTT on protein misfolding and hydrophobic exposure was measured using
fluorescent dye ANS and its dimeric analog bis-ANS. ANS is highly fluorescent and
blue shifts (peak maximum shifts to 470 nm) upon binding to the hydrophobic core of
the protein45. The dimeric analog of ANS, bis-ANS shares similar properties to ANS
but has a higher binding affinity for molten globule like structures of proteins (Figure
3.5). Both dyes exhibit similar trends with rapid increase in fluorescence intensity in
the first h followed by high but steady fluorescence emission at longer incubation times.
In presence of disulfide-reduced insulin at 172 µM concentration, ANS shows rapid
increase in fluorescence in the first few min of incubation that peaks and then steadies
in 1 h (Figure 3.5A). The peak wavelength for ANS stays steady at ~470 nm for the
length of incubation (Figure 3.6). The disulfide reduced insulin at 90 and 20 µM also
showed emission spectra similar to that seen for 172 µM protein (Figure 3.7A, 3.7C).
Interestingly, at these lower protein concentrations the peak wavelength for ANS that
is initially around 500 nm shifts to ~470 nm in about 20 min and stays steady at ~ 470
nm even upon longer incubation (Figure 3.7B, 3.7D). This suggests that disulfide
reduced insulin unfolds and the hydrophobic amino acid residues that are initially
solvent exposed collapse and aggregate burying the hydrophobic residues (Figure 3.7).
At protein concentration of 172 µM the unfolded protein burden is very high and it
rapidly undergoes hydrophobic collapse aggregating with peak wavelength observed
at ~470 nm (Figure 3.6). Controls (proteins with intact disulfide bonds) did not show
change in fluorescence as a function of time. This is in line with other protein
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aggregation studies where exposure of hydrophobic amino acids is followed by
collapse and burial of the hydrophobic core35, 46-48.
ThT was used to investigate the nature of insulin aggregates. ThT showed very rapid
increase in fluorescence in the first 1 h of incubation with disulfide reduced insulin
followed by gradual increase in fluorescence for the rest of the length of incubation
(Figure 3.8). This observed trend of fluorescence increase for ThT is similar to earlier
protein aggregation studies suggesting amyloid formation

27, 49-51

. The interaction

between ThT molecules and amyloid β-sheets results in high fluorescent emission at
480 nm45. However, some other studies have shown that ThT dye can also interact with
large amorphous aggregates by stacking in between the aggregates, leading to increased
fluorescence

52, 53

. Therefore, ThT fluorescence alone cannot accurately provide

structural information about protein aggregates and needs further independent
verification. We used SEM to image the aggregates and visualize the morphology of
these aggregates. Electron microscope images show that the aggregates are amorphous
in nature (Figure 3.9 to 3.11) that stay amorphous even upon longer incubation (Figure
3.11). Size of aggregates ranged between 100-200 nm, depending on the length of
incubation (Figures 3.9 to 3.11)30. Comparing the aggregates formed during the first 15
min (Figure 3.9A) with longer incubation time, the density of aggregates was seen to
increase dramatically with time (Figure 3.10) but the nature of aggregates remained
amorphous. As shown, large insulin aggregates were made of smaller units, suggesting
a mechanism similar to ‘chain polymerization’ (Figure 3.10). This implies that
unfolded insulin monomer comes together to form multimers that in turn join together
to form macromolecular aggregates. SEM image of fresh insulin with DTT (control
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sample, Figure 3.10) shows very few aggregates that rapidly increases in size and
number of aggregates in the first 15 min, after which the change is not as dramatic.
This is in line with the observed data for unfolding, misfolding, and aggregation
kinetics of insulin (Figures 3.3 to 3.8). Studies by several groups have suggested that
amorphous aggregates are precursors of amyloid fibrils31, 37, 54, 55. In order to test if
disulfide-reduced insulin at physiological pH that is initially observed as amorphous
aggregates turn into fibril; we imaged similarly incubated insulin (pH 7.2, 37 °C)
samples after 6 months (Figure 3.11). We only observed amorphous aggregates even
after such a long incubation time under the experimental conditions (Figure 3.11).
These results are in line with other reports showing formation of amorphous aggregates
even upon longer incubation31, 56, 57.
Salt has been shown to accelerate protein aggregation58, 59. Effect of salt concentration
was illustrated in the absence and presence of NaCl (150 or 300 mM) (Figures 3.12 to
3.117). Aggregation kinetics showed trends that were similar for proteins with/without
NaCl and the results were comparable to our earlier results (Figure 3.3 to 3.8), at all
protein concentrations (Figures 3.12 to 3.17). This suggests that insulin aggregation
under reducing conditions is independent of ionic strength at pH 7.2. These results are
in line with another study where chaotropic role of NaCl was absent in the process of
insulin aggregation, both at acidic and at neutral pH11.
Insulin has been shown to aggregate at repeated injection sites of diabetic patients
leading to a critical medical condition known as injection amyloidosis8. Many studies
have shown that aggregation of proteins is propagated by a nucleation-dependent
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polymerization method where a “nucleus” is formed by assembly of monomers.
Although, this process is thermodynamically and kinetically unfavorable, it decreases
the energy barrier for aggregation, reducing the lag time and shifting the equilibrium
towards unfolded state of the protein24, 60. To understand how nucleation can impact
aggregation of native insulin we prepared “seeds” by incubating insulin in the presence
of 10 mM DTT for 10 min, 30 min to 4 h (30 min interval), and 5 h to 12 h (1 h interval).
Effect of seeding on native insulin aggregation was monitored by ThT fluorescence
(Figure 3.26). The ThT fluorescence data for different timed seeds up to 4 h was fitted
and analyzed by linear regression (Figure 3.23 to 3.25). The slope of the curves shows
the kinetics of aggregation (Table 3.1). Aggregation kinetics of native insulin in the
presence of 10-min seeds was maximum with a slope of 235.92±4.86 (Table 3.1);
followed by seeds made by incubating insulin for 30 min and 4 h. Aggregation of native
insulin in the presence of seeds prepared by incubating protein for 5 h or longer (up to
12 h) had the slowest aggregation kinetics (Figure 3.25). Therefore, these seeds were
grouped into nascent (10 min), intermediate (30 min to 4 h) and mature (5 h to 12 h)
seeds based on the difference in their aggregation kinetics (Table 3.1, Figure 3.23 to
3.25).
The rate of aggregation increases continuously in the presence of nascent seeds at a
concentration of 5% and 15% v/v (Figure 3.18, 3.19). However at a concentration of
45% (Figure 3.20), the aggregation rate is independent of “stage” of seeds (nascent,
intermediate, or mature seeds) used to initiate aggregation. This maybe a result of
saturation of the number of nucleation sites available for aggregation. This establishes
the critical concentration of seeds necessary for proteins to aggregate in vitro and that
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still shows a difference in aggregation kinetics. In summary, nascent seeds had the
shortest lag time and fastest aggregation kinetics. This suggests that nascent seeds of
insulin have high number of soluble misfolded proteins with exposed hydrophobic
surface providing very high number of nucleation sites for native insulin to bind and
aggregate compared to seeds prepared by longer incubation. The kinetics of
aggregation was also observed to linearly depend on the seeding concentration in the
presence of nascent seeds (Figure 3.27). This suggests that at higher seed concentration
(e.g. 15% seed v/v) the number of available nucleation sites for seeds are more
compared to seed concentration of 5% v/v and hence higher aggregation rate observed
at higher concentration (Figure 3.27). This is in line with another study that suggests
partially-folded protein intermediates promote aggregation and not the mature
aggregates35.
Morphology of the aggregates formed as a result of seeding were characterized by
atomic force microscopy (Figure 3.21, 3.22). The aggregates formed by native insulin
incubated with nascent or intermediate seeds increased in size from 10 nm to 400 nm.
Stiffness of aggregates as measured by Young’s modulus ranged between 4 ± 0.6 to 6
± 0.2 GPa for the aggregates formed by nascent and intermediate seeds, which is
comparable to values reported in literature61-64. These values suggest that the
aggregates are relatively rigid and the high tensile strength of these aggregates maybe
a result of strong hydrogen bonding as well as hydrophobic interactions contributing to
the mechanical stiffness of the structure64,

65

.

Interestingly, native insulin when

incubated with intermediate seeds formed fibrils (Figure 3.21 B, C) that converted to
amorphous aggregates upon longer incubation (24 h or more) (Figure 3.22). The
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secondary structure of nascent and intermediate seeds along with native insulin
(control) was investigated using FT-IR66, 67 to understand the morphological diversity
of the seeds (Figure 3.28). A peak at 1656 cm-1 was observed for native insulin that is
characteristic of α-helical proteins68-71. All the seeds show a peak at 1625 cm-1 that is
characteristic of β-sheet structure. The raw spectra were deconvoluted and fitted using
Gaussian function to obtain the major component peaks. Area under the deconvoluted
peaks were integrated to calculate the percent contribution from α-helical or β-sheet
structures, for each seeds. The α-helical content decreased with increase in incubation
time. Nascent seeds (10 min) had nearly 63% of α-helical and 37% of β-sheet structures
(Figure 3.28). This ratio changed to ~50% α-helical and ~50% β-sheet for intermediate
seeds (4 h). This suggests that the nascent seeds have significant native structure (αhelix) that can contribute to native insulin aggregation in a nucleation dependent
manner. In nascent seeds the α-helical structure acts as the site of nucleation for native
insulin and the β-sheet component propagates the aggregation process in a templatedependent manner. Intermediate seeds (30 min to 4 h) could also promote aggregation
of native insulin due to the presence of significant α-helical structure (50% to 60%)
present in them. AFM images of intermediate seeds incubated with native protein show
formation of protofibrillar to fibrillar structures. This observation is complemented by
FTIR data wherein increase in β-sheet structure is observed for both 1 and 4 h seeds.
Kinetic data shows that 1 h seed is most efficient among intermediate seeds, in
aggregating native insulin, which suggests that protofibrils are more efficient than
fibrils in aggregating native insulin (Table 3.1, Figure 3.28). Conversion of fibrils to
amorphous aggregates within 24 h of incubation under our experimental conditions
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shows the transient nature of these aggregates (Figure 3.29). This is in line with
amorphous aggregates observed for disulfide-reduced insulin incubated at 37 °C for six
months in this study. Overall, this study and an earlier study shows that proteins under
conditions that are reducing and close to physiological favor formation of amorphous
aggregates57.

Figure 3.29 Plausible aggregation mechanism model based on insulin aggregation in
presence of different timed seeds. Nascent seeds promote rapid amorphous aggregate
formation; intermediate seeds lead to formation of fibrillar structure in 4 h that converts
to amorphous upon longer incubation of 24 h. Aggregation in the presence of mature
seeds is very slow when compared to nascent and intermediate seed kinetics.

120

Conclusion
In summary, this study measures the aggregation kinetics and characterizes the nature
of aggregates of insulin formed under disulfide reducing conditions at pH 7.2 and 37
°C. The results show that insulin aggregates rapidly under these conditions and forms
amorphous aggregates that stay amorphous even upon incubation for six months. Seeds
affect native insulin aggregation kinetics; with nascent seeds showing the fastest
aggregation kinetics. Interestingly, incubation of native insulin with intermediate seeds
for shorter period (4 h) results in fibril formation that converts to amorphous upon
longer incubation (24 h). These results suggest that insulin favors amorphous aggregate
formation under disulfide reducing conditions at physiological pH and temperature.
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Abstract
Observation of protein aggregates in end stage tissues is hallmark of several
neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer’s and
Parkinson’s disease. However, the relationship between morphology of aggregated
proteins and their associated toxicity is not clear. To better understand the relationship
between distinct aggregated forms of proteins and their toxicity, we used insulin as a
model protein. Morphologically distinct insulin aggregates were prepared by
incubating the protein at various pH (2.0, 5.3, 7.0 and 8.8) and temperature (37 °C or
65 °C) in presence or absence of disulfide reducing agent. The morphology and unique
physic-chemical properties of the aggregates were characterized using spectroscopy
and electron microscopy techniques. Insulin aggregates within 4 h in the presence of
reducing agent at all pH studied. At acidic pH (pH 2.0 or pH 5.3) it forms rod-like
aggregates at 37 °C and fibrils at 65 °C in absence of reducing agent. In the presence
of reducing agent, insulin forms amorphous aggregates with distinct morphology at pH
2.0 and 7.0. At pH 5.3 and 8.8, filamentous structures of varying lengths were observed.
The cytotoxicity of these distinct aggregates were measured using human
neuroblastoma (SH-SY5Y) cells. Overall, the results show that aggregates formed
under disulfide reducing conditions at acidic pH were more toxic.
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Introduction
Proteins are functional within a narrow range of temperature and pH, deviation from
which leads to physical and/or chemical instability causing them to aggregate.
Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Parkinson’s and
Alzheimer’s disease are a result of protein misfolding and aggregation1-4. However, the
general mechanism by which these aggregates cause toxicity is not well understood.
This is further complicated by the fact that there is no clear relationship between the
morphology and toxicity of these aggregates. This diversity has been observed between
different proteins as well as within mutants of the same protein5, 6. Majority of these
disease causing proteins form β-sheet rich structures in vivo that are collectively known
as amyloid fibrils, however structurally distinct fibrils have been observed in Aβ1-42
and prion protein aggregates7, 8. These fibrils were also shown to possess diverse
interaction patterns. Heterogeneous aggregate forms have also been observed in tissuederived aggregates of lysozyme, apolipoprotein and tau protein with disparate
cytotoxicity7. Amyloid deposits have been occasionally found to contain alternate
aggregate forms within amyloid plaques. These include Creutzfeld-Jacob disease,
Down’s syndrome and rat model of Alzheimer’s disease 9-13. In vitro studies have also
reported the formation of alternate aggregate forms in pathogenic Ig light chain, human
serum albumin, lysozyme, β-lactoglobulin, insulin, and in solution of 40-residue Aβpeptide 14-21. Studies with Aβ protein have shown that the longer peptide (1-42) is more
toxic to neuronal cells than Aβ1-40 and form amylospheroid like structures 22. Mature
aggregate forms of Aβ1-42 exhibited high toxicity even at nano-molar concentrations
when compared to immature oligomers23. Other disease related proteins such as
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superoxide dismutase 1 (SOD1) also exhibit toxicity due to lack of copper and/or zinc
in both wild type and mutant protein forms24. Although, a host of information is
available on aggregate morphology and cytotoxicity from both in vitro and in vivo
studies, yet the relationship between structure and toxicity of these aggregates is still a
matter of debate. These observations suggest that the morphology of protein aggregates
is highly dependent on aggregation conditions such as temperature, pH and other
stresses in the cellular environment.
To better understand role of misfolded proteins in the disease process, we need to
characterize the structural changes in proteins due to change in pH, temperature, and
external stresses and correlate aggregate morphology to its toxicity. The goal is to
generate distinct aggregate forms from a single protein by manipulating the proteins
local environment and test its toxicity. For this we chose a commonly studied model
protein insulin as it can generate distinct aggregate forms. Insulin is an aggregation
prone protein that forms fibrils at low pH and forms spherulites at elevated
temperatures (65 – 75 oC)

18, 25-29

, and amorphous aggregates near neutral pH under

disulfide reducing conditions44.
Insulin is a 51-residue protein consisting of two polypeptide chains A and B with 21
and 30 residues respectively. There are two inter-chain disulfide bonds (A7-B7, A20B19) and one intra-chain disulfide bond (A6-A11) that substantially constrain the
structure and native fold of insulin30, 31. The intra-chain disulfide bonds are buried
within the hydrophobic core of the protein. Insulin aggregation has been studied
extensively only at acidic pH due to ease of fibril formation, whereas fewer studies
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have been done at physiological pH where amorphous aggregates and particulates are
prevalent.32-37. Insulin stability is dictated by its conserved residues (Val A3, Ile A13 ,
Val B12 , Val B18 , Phe B24 , and Tyr B26) that are solvent exposed. At acidic pH, the net
charge on these amino acid residues become positive owing to their isoelectric point
ranging between 5 and 6, leading to destabilization of the native fold and subsequent
aggregation38. It is known that disulfide bridges are retained in the insulin fibrillation
process and also the individual chains are capable of fibrillation that are structurally
different from the intact insulin fibril39, 40. Partial reduction of disulfide bonds in the
presence of tris(2-carboxyethyl)phosphine (TCEP) at low pH lead to the formation of
flexible filaments of bovine insulin40. Toxicity of filaments formed from reduced
bovine insulin at pH 1.6 is considerably lower than fibrils formed from insulin with
intact disulfide bridges 40. Insulin oligomers and fibrils at acidic pH have been found to
be toxic to PC-12 and SH-SY5Y cell lines41, 42. However, a systematic study on insulin
aggregates formed at other pHs and temperature toxicity information of aggregates
formed at different pH and temperature under disulfide reducing conditions is lacking.
Hence it is important to understand the factors that trigger the formation of these
alternate forms of aggregates, their morphology and the relationship to cytotoxicity.
Having a better understanding of different aggregated forms of insulin and its
relationship to cellular toxicity can help shed light on other protein aggregation diseases
owing to the generic mechanism of protein aggregation 3.
In this study, we prepared aggregates at acidic, neutral, and basic pH and also at the
isoelectric point (pH 5.3)43 of insulin. Aggregation of insulin at pH above and below
its isoelectric point is important for understanding the effect of net charge on the protein
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and its contribution towards protein unfolding and subsequent aggregation. The
aggregates were prepared by incubating insulin at physiological (37 oC) and elevated
(65

o

C) temperature to investigate the temperature dependence of aggregate

morphology and aggregation kinetics. Disulfide bonds are central to protein stability
and reduction of disulfide bonds can lead to aggregation in protein including
insulin44,45. Therefore, to understand the effect of disulfide bond reduction on insulin
aggregation and toxicity, we used 10 mM tris(2-carboxyethyl)phosphine (TCEP) – a
non-thiol based reducing agent. Comparing and contrasting the distinct aggregate
forms of insulin and their toxicity at different pHs, temperature, and oxidizing/reducing
conditions will lead to a better understanding of the relationship between different
aggregate forms and their toxicity.
In this study, we demonstrate that insulin forms fibrils at acidic pH (2.0 and 5.3) but
forms largely amorphous structures at basic pH (8.8), in the absence of TCEP. Insulin
incubated without TCEP at pH 7 and 37 oC did not show any aggregation. In the
presence of the reducing agent short, branched and long filaments were formed at pH
5.3 and 8.8, respectively. Amorphous aggregate forms dominate at acidic and neutral
pH. Comparison of the toxicity levels of the various aggregates show that insulin
aggregates formed in the presence of reducing agent are more toxic to SH-SY5Y cells
compared to non-reduced protein aggregates. We also observed that loose amorphous
and globular aggregates formed at pH 2.0 are most toxic followed by the filamentous
(short, branched and long) structures formed at the isoelectric point as well as basic pH,
respectively. Interestingly, incubation temperature plays an important role in
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accelerating the aggregation process, rather than altering the overall morphology and
cytotoxicity of the aggregates.

Materials and Methods
Unless otherwise indicated, all materials were used as supplied by the manufacturer
without

any

further

purification.

Human

recombinant

insulin,

tris(2-

carboxyethyl)phosphine (TCEP), thioflavin T (ThT), 8-anilino-1-naphthalenesulfonic
acid (ANS) dye, 4,4′-Dianilino-1,1′-binaphthyl-5,5′- disulfonic acid (Bis-ANS) dye
were purchased from Sigma.
Preparation of insulin samples - Insulin stock solutions were prepared as described
earlier44. All insulin samples were prepared to a final concentration of 1 mg/mL in 20
mM of respective buffers at pH 2.0 (Glycine-HCl), pH 5.3 and 8.8 (Tris-HCl), pH 7.0
(HEPES), either in presence or absence of 10 mM tris(2 carboxyethyl)phosphine
(TCEP). The samples were prepared on ice followed by incubation both at 37 oC and
65 oC for the indicated time periods (see figures for details). Blanks (contained
everything except insulin) were similarly prepared and incubated as samples and were
used for background subtraction.
Intrinsic and extrinsic fluorescence- Fluorescence measurements were carried out
using a Horiba Jobin Yvon spectrofluorometer (Fluoromax-4). Excitation and emission
slit widths were set at 2 nm, each. For intrinsic fluorescence, emission spectra were
acquired from 285 to 450 nm with excitation at 280 nm. For extrinsic fluorescence,
emission spectra were acquired in presence of 10 µM ThT, 5 µM ANS, or 1 µM BisANS. The concentrations of dye stocks were determined using their extinction
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coefficients: ANS ε350 nm = 5000 M-1 cm-1, bis-ANS ε385 nm = 16790 M-1 cm-1, and ThT
ε416 nm = 26,620 M-1 cm-1. Protein samples were diluted to a final concentration of 90
µM using 20 mM of respective buffers for intrinsic, ANS and Bis-ANS fluorescence
measurements. A final sample concentration of 30 and 15 μM were used for ThT
fluorescence measurements. After timed incubation, diluted protein samples were
equilibrated with respective fluorophores on ice, in dark for 30 min before acquiring
the spectra. For ThT fluorescence, emission spectra were collected from 460 to 650 nm
with excitation at 450 nm. Fluorescence spectra from 400 to 700 nm were collected
with excitation at 380 nm for ANS and at 360 nm for bis-ANS. All measurements were
done in triplicates.
Fitting of ThT Fluorescence Data – ThT fluorescence data in the absence of reducing
agent at pH 2.0 and 5.3 at 65 oC was fitted using a Gompertz function given by 𝑦𝑦(𝑡𝑡) =

𝐴𝐴. 𝑒𝑒

(𝑡𝑡−𝑡𝑡𝑖𝑖 )

−𝑒𝑒 𝑏𝑏

where 𝑡𝑡𝑖𝑖 is the lag time and b is the apparent aggregation rate

63

. This

function is used to fit sigmoidal growth/aggregation curves with relatively long lag
times.
Field Emission Scanning Electron Microscopy (FESEM) – Electron microscope
images were collected using Hitachi S-4700 field-emission scanning electron
microscope (FESEM). Samples incubated for indicated times were diluted 4-fold with
MQ water and aliquoted in Millipore Amicon® Ultra centrifugal filters (3 kDa cut off).
The diluted samples were centrifuged at 7000 x g at 4 oC (three repeats after dilution
with water) to remove low molecular weight impurities (salt, buffer etc). The washed
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samples were aliquoted on SEM stubs and air-dried. The samples were platinum coated
using a sputter coater and imaged using an acceleration voltage of 5 kV.
Cell Culture – Human neuroblastoma (SH-SY5Y) cells were maintained in DME/F12
medium containing 10% fetal bovine serum, 100 U/mL penicillin and 100 μg/mL
streptomycin in 5% CO2 at 37 oC.
Toxicity Assay – Cell viability was determined using CellTiter 96® AQueous One
Solution Cell Proliferation Assay (MTS). It is based on the formation of formazan from
tetrazolium salt by mitochondrial dehydrogenase. This reaction changes the color of
viable cells to dark purple-blue and its absorbance is measured spectrophotometrically
at 490 nm. The percentage of viable cells was determined using the absorbance of
control cells as 100%.
Insulin samples were washed with double-distilled water and diluted to a final
concentration of 10 μM using cell-growth medium. Cells were plated in 96-well plates
at a density of 15000 cells/well and grown overnight. The cells were then incubated
with 100 μL of medium with and without insulin aggregates and incubated for 48 hours
in 5% CO2 at 37 oC. Blanks containing insulin samples and medium were also
incubated similarly, and used for background subtraction. After incubation, 20 μL of
MTS reagent was added to each well and incubated for 4 hours at 37 oC, 5% CO2
incubator. The absorbance of the cells was read using a micro-plate reader at 490 nm.
All measurements were done in triplicates.
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Figure 4.1 Ribbon structure of insulin (A) monomer at pH 2.0, (B) dimer at pH 5.3,
and >8, and (C) hexamer at pH 7.0 showing the disulfide bonds (S−S, sand-yellow).
The backbone is shown in gray color. The structures were generated using PyMOL 1.3
and PDB files 1GUJ for monomer and 1AI0 for dimer and hexamer.
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Figure 4.2 Protein misfolding and hydrophobic exposure monitored by ANS
fluorescence. Insulin samples incubated at a concentration of 172 μM were diluted to
a final concentration of 90 μM and incubated with 5 μM ANS for 15 minutes before
acquiring spectra. Emission spectra were collected from 400-650 nm with excitation at
380 nm for (A) pH 2.0 (B) pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission
wavelength of 467 nm was selected. Peak fluorescence intensities are shown using open
symbols (without TCEP) and closed symbols (10 mM TCEP). Data is representative of
triplicates with error bars showing ± SD.
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Figure 4.3 Protein misfolding and conformational tightening monitored by Bis-ANS
fluorescence. Insulin samples incubated at a concentration of 172 μM were diluted to
a final concentration of 90 μM and incubated with 1 μM Bis-ANS for 15 minutes before
acquiring spectra. Emission spectra were collected from 400-650 nm with excitation at
360 nm for (A) pH 2.0 (B) pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission
wavelength of 482 nm was selected. Peak fluorescence intensities are shown using open
symbols (without TCEP) and closed symbols (10 mM TCEP). Data is representative of
triplicates with error bars showing ± SD.

143

Figure 4.4 Protein aggregation monitored by ThT fluorescence. Insulin samples
incubated at a concentration of 172 μM were diluted to a final concentration of 90 μM
and incubated with 10 μM ThT for 30 minutes before acquiring spectra. Emission
spectra were collected from 460-650 nm with excitation at 450 nm for (A) pH 2.0 (B)
pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission wavelength of 486 nm was
selected. Peak fluorescence intensities are shown using open symbols (without TCEP)
and closed symbols (10 mM TCEP). Data is representative of triplicates with error bars
showing ± SD.
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Figure 4.5 Protein misfolding and hydrophobic exposure monitored by ANS
fluorescence. Insulin samples incubated at a concentration of 172 μM were diluted to
a final concentration of 90 μM and incubated with 5 μM ANS for 15 minutes before
acquiring spectra. Emission spectra were collected from 400-650 nm with excitation at
380 nm for (A) pH 2.0 (B) pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission
wavelength of 467 nm was selected. Peak fluorescence intensities are shown using open
symbols (without TCEP) and closed symbols (1 mM TCEP).
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Figure 4.6 Protein aggregation monitored by ThT fluorescence. Insulin samples
incubated at a concentration of 172 μM were diluted to a final concentration of 90 μM
and incubated with 10 μM ThT for 30 minutes before acquiring spectra. Emission
spectra were collected from 460-650 nm with excitation at 450 nm for (A) pH 2.0 (B)
pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission wavelength of 486 nm was
selected. Peak fluorescence intensities are shown using open symbols (without TCEP)
and closed symbols (1 mM TCEP).

146

Figure 4.7 Rate of protein aggregation calculated using ThT fluorescence data. Insulin
samples incubated at a concentration of 172 μM were diluted to a final concentration
of 45 μM and incubated with ThT as detailed in Figure 4. Apparent rate of aggregation
and lag time for (A) pH 2.0 and (B) pH 5.3 in the absence of TCEP at 65 oC were
calculated after fitting the data to Gompertz growth function. The data points are
experimental values fitted using the function. Data is representative of triplicates with
error bars showing ± SD.
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Figure 4.8 FE-SEM Images of insulin aggregates without TCEP. One hundred seventy
two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 4 h at pH 2.0 (A, E),
pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for all images.

Figure 4.9 FE-SEM Images of insulin aggregates with 10 mM TCEP. One hundred
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 4 h at pH
2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for all
images
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Figure 4.10 FE-SEM Images of insulin aggregates without TCEP. One hundred
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 72 h at pH
2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for all
images.

Figure 4.11 FE-SEM Images of insulin aggregates with 10 mM TCEP. One hundred
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 72 h at pH
2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for all
images.
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Figure 4.12 FE-SEM Images of insulin aggregates without TCEP. One hundred
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 7 days at
pH 2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for
all images.

Figure 4.13 FE-SEM Images of insulin aggregates with 10 mM TCEP. One hundred
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 7 days at
pH 2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for
all images.
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Figure 4.14 ThT emission spectra and SEM Images of insulin aggregates incubated for
4 weeks. One hundred seventy two μM insulin was incubated at pH 2.0 (A), pH 5.3
(B), pH 7.0 (C) and pH 8.8 (D) in the presence and absence of 10 mM TCEP at 37 and
65 oC. Samples were diluted to a final concentration of 15 μM and incubated with 10
μM ThT for 30 min on ice. Emission spectra was acquired from 460-650 nm after
excitation at 450 nm. Insets show SEM images after 4 weeks of incubation for each pH
in the absence (a, b; e, f; i, j; m, n) and presence (c, d; g, h; k, l; o, p) of 10 mM TCEP
at 37 oC (a, c; e, g; i, k; m, o) and 65 oC (b, d; f, h; j, l; n, p). Scale bar is 5 μm for all
images. Data is representative of average of triplicates.
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Figure 4.15 Cytotoxicity effects of insulin aggregates by MTS assay. Aggregates were
prepared by incubating 172 μM protein for 7 days, at all the indicated conditions and
were diluted with cell growth medium. SH-SY5Y cells were plated in 96 well plates at
a density of 15000 cells per well and grown overnight. Cells were then incubated in the
absence (control) and presence of 10 μM insulin aggregates. Data is representative of
triplicates with error bars showing ± SD.
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Results & Discussion
Insulin aggregation has been extensively studied and serves as a model protein for nonneuropathic systemic amyloidosis and other amyloid diseases

47

. Insulin is known to

aggregate rapidly and form fibrils at acidic pH as well as in the presence of chaotropic
agents such as urea, guanidine hydrochloride etc.

33, 35, 36, 39

. Spherulite and filament

formation of insulin has also been observed in in vitro studies at high temperatures and
acidic pH

25-27

. Few studies have also shown formation of amorphous aggregates of

insulin at physiological conditions44. This suggests that insulin follows alternate
aggregation pathways that are triggered by external conditions such as temperature, pH
and oxidizing/reducing stresses, among others. The potential correlation between
diverse aggregate forms to disease processes requires information about toxicity as
well. Alternate aggregate forms of proteins such as spherulites and gels have been
observed within amyloid plaques in certain diseases, although toxicity information of
these aggregates are unknown12. Insulin fibrils and pre-fibrillar oligomers at acidic pH
are known to be cytotoxic but toxicity details on alternate aggregate forms are
unavailable

41, 42

. Therefore we wanted to study the mechanism of aggregation of

various forms of insulin aggregates, measure its associated kinetics, and understand the
relation between aggregate structure and its cytotoxicity.
We monitored insulin aggregation kinetics at pH 2.0, 5.3, 7.0 and 8.8 in the absence
and presence of reducing agent (10 mM TCEP) at 37 and 65 oC using various
spectroscopic techniques (Figures 4.2-4.7, 4.14). Morphology of various aggregate
forms was characterized using SEM (Figures 4.8-4.13). Insulin forms morphologically
diverse aggregates with distinct spectral properties in the absence and presence of
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reducing agent. Cytotoxicity of the diverse aggregate forms was elucidated using
human neuroblastoma SH-SY5Y cells (Figure 4.15).
Insulin structure changes with change in pH. Zn-insulin shifts from monomer to its
dimeric form at acidic pH with the equilibrium shifting towards the dimer with increase
in pH. The protein is predominantly hexamer at neutral/physiological pH (Figure 4.1)34,
48, 49

. Beyond pH 7.4 insulin dissociates to form dimers due to loss of zinc binding that

is facilitated directly by histidine at position B1050. These associations are
predominantly dependent on the net charge on the protein and hence are dictated by the
solution pH.
Insulin aggregation and conformational change due to hydrophobic exposure was
monitored using extrinsic fluorescent dye ANS (Figure 4.2). This dye is highly
sensitive to its local environment and causes increase in fluorescence intensity and a
corresponding blue shift when it binds to hydrophobic pockets of proteins. Quenching
of fluorescence intensity and red shift is observed upon exposure to polar environment.
Insulin incubated in the absence of TCEP at 37 oC did not show increase in fluorescence
for the entire incubation period. However, with increase in incubation temperature to
65 oC, fluorescence intensity does not increase up to 72 h and 7 days respectively for
pH 2.0 and 5.3 (Figures 4.2A, 4.2B), beyond which fluorescence intensity increased
very rapidly. Insulin exists as a monomer at acidic pH and it self-associates to form
dimer near its isoelectric point. The monomer has two hydrophobic surfaces on each
side that are capable of ANS binding and increase in fluorescence intensity. This is in
line with the observation that fluorescence intensity rapidly increases after a lag time
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of 72 h at pH 2.0, 65 oC. Dimerization of insulin with increase in pH, leads to burial of
hydrophobic residues to some extent that is explained by the increase in lag time of
aggregation from 72 h to 7 days in case of pH 5.3. Marginal increase in fluorescence is
observed at neutral pH, however at basic pH it remained unaffected with increase in
incubation temperature from 37 oC to 65 oC (Figures 4.2C, 4.2D). This suggests the
absence of unfolding and exposure of hydrophobic residues at this pH due to presence
of predominantly dimeric form of the protein at pH 8.8. Insulin aggregation at 37 oC
was independent of the pH change, under our experimental conditions. This can be
explained in light of previous studies that elevated temperature and/or other stresses
are important to overcome the activation barrier in order to shift the equilibrium
towards the unfolded state of the protein51. Earlier studies have shown that insulin
aggregates at 37 oC within two weeks of incubation with continuous agitation 41.
In the presence of reducing agent, ANS fluorescence of insulin (Figures 4.2A, 4.2B)
showed a rapid increase for the first 4 h for all pH studied. Beyond 4 h fluorescence
intensity decreased and steadied for both incubation temperatures, in case of pH 2.0
and 5.3. At pH 7.0 and 8.8, decrease in fluorescence intensity beyond 4 h was
continuous till the entire incubation time in case of 65 oC (Figures 4.2C, 4.2D). The
amount of reducing agent used is enough to scramble the disulfide bonds of insulin.
This causes unfolding and exposure of hydrophobic residues within 4 hours followed
by hydrophobic collapse and burial that is marked by decrease in fluorescence intensity.
Similar trends were observed in an earlier study with insulin at physiological pH and
temperature 44.
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We used Bis-ANS, a dimeric analog of ANS to study the conformational flexibility of
the insulin aggregates (Figure 4.3). Bis-ANS is known to fluoresce on binding to
flexible molten-globule structures rather than highly rigid and hydrophobic structures.
This property was used to assess the conformational tightening of insulin aggregates.
Insulin in absence of reducing agent at 37 oC did not show significant change in
fluorescence intensity over the 14 days incubation time. At 65 oC temperature, insulin
in the absence of reducing agent showed fluorescence intensity increased rapidly within
4 h followed by a gradual decrease in intensity, at pH 5.3, 7.0 and 8.8 (Figures 4.3B,
4.3C, 4.3D). However, at pH 2.0 (Figure 4.3A), intensity dropped beyond 4 hours
followed by gradual increase after 48 h of incubation time. This suggests that at pH 2.0
and 5.3 newly formed aggregates (initial 4 h) are flexible that bind to Bis-ANS however
with time the aggregates reorient themselves to form tighter conformations that is
signified by the drop in fluorescence intensity past 4 h of incubation. For TCEP-treated
insulin at both temperatures (37 and 65 oC) and all pH (2.0, 5.3, 7.0 and 8.8) bis-ANS
fluorescence increased rapidly for 4 h followed by a gradual decrease signifying the
formation of flexible aggregates that reorient to eventually form rigid structures leading
to decrease in fluorescence.
Morphology of insulin aggregates were monitored using ThT fluorescence (Figure 4.4,
4.7) and further confirmed by scanning electron microscopy (Figures 4.8-4.13). ThT is
classically known to bind to amyloid fibrils with a characteristic fluorescence. Insulin
aggregates in oxidizing environment at 37 oC (all pH) did not show any fluorescence
for the entire incubation time. This supports the ANS and bis-ANS fluorescence data
confirming the non-existence of hydrophobic pockets or large aggregate forms at
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physiological temperature incubation conditions. Electron micrographs confirm the
fluorescence data finding. At acidic (2.0 and 5.3) and basic pH (8.8), insulin formed
rod-like and amorphous aggregates respectively, without the characteristic
fluorescence. This suggests the possibility that at physiological temperature, the cavity
of aggregates formed is < 8 Å where ThT molecule could bind without inducing
fluorescence 52. No aggregation was observed at neutral pH at 37 oC that is in line with
an earlier study44.
Insulin incubated at elevated temperature (65 oC) in the absence of reducing agent,
show drastic increase in ThT fluorescence after 4h, 72 h and 7 days of incubation in
case of pH 2.0 and 5.3 (Figure 4.4). The behavior is similar to that of ANS fluorescence
(Figure 4.2) confirming that the aggregates formed at acidic pH is either fibrils or large
structures with significant hydrophobic exposure. SEM images of the aggregates
confirmed fibril formation for both pH conditions (Figures 4.8, 4.10, 4.12).
Fluorescence intensity at pH 7.2 and 8.8 were almost half compared to acidic pH and
the aggregates observed by SEM were amorphous. Earlier studies have shown that ThT
can bind to large amorphous structures and the fluorescence is almost one-fifth to that
of fibrils, in this case 52. Increased fluorescence intensity of amorphous aggregates of
insulin at pH 8.8, as compared to the study by Yang et al. (2015) suggests at the
aggregate cavity size is > 8 Å leading to increase in ThT fluorescence45.
TCEP-treated insulin at both incubation temperatures follows similar trends. At pH 2.0,
5.3 and 7.0, fluorescence intensity gradually increases for the 14 days incubation
period, although at pH 8.8, ThT fluorescence decreases after 7 days of incubation. This
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suggests that reduced insulin follows similar aggregation pattern that is more or less
independent of the pH. The aggregate formation is slow with typically low cps counts
that might be accounted by the small size of cavity of the ThT molecule to bind.
Electron micrographs show amorphous aggregate formation in the presence of TCEP
at pH 2.0 and 7.0 (both temperatures) whereas filamentous structures were observed at
the isoelectric point and basic pH (Figures 4.9, 4.11, 4.13). An earlier study with TCEP
induced bovine-insulin aggregation showed formation of filamentous aggregates at pH
1.6 and high temperature, which is contrary to the observation under our experimental
conditions

40

. However, the authors found intact fibrils in the absence of TCEP that

support our findings.
We also wanted to understand whether decreasing the concentration of reducing agent
decreased the kinetics of aggregation or altered the mechanism as well. We
characterized insulin aggregates formed in the presence of 1 mM TCEP using ANS and
ThT fluorescence (Figures 4.5, 4.6). We observed overall decrease in fluorescence
intensity although the fluorescence trend remained unaltered, thereby confirming
slower aggregation kinetics without altering the aggregation mechanism.
The aggregation kinetics at pH 2.0 and 5.3 in the absence of TCEP at 65o C, followed
a characteristic sigmoidal trend with a lag phase, growth phase and saturation phase of
aggregate formation (Figure 4.7). Hence, ThT fluorescence data was fitted to a
Gompertz growth function. This function provides the best fit to sigmoidal curves with
long lag times and assumes first order reaction kinetics

53-56

. The fitted function was

used to calculate the lag time and apparent rate of aggregation in the fibrillation process
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for both pH studied. At pH 2.0, insulin aggregated with a lag time of 137.7 h and
apparent aggregation rate was 0.244 s-1. In case of pH 5.3, lag time and aggregate rate
were 327.5 h and 0.052 s-1 respectively. This suggests that lag time of aggregation
almost doubles with increase in pH with significantly slower rate (roughly one-fourth).
The driving force of insulin aggregation is the acidic environment that leads to insulin
monomer formation followed by rapid aggregation.
Insulin formed diverse aggregate forms in oxidizing (0 mM TCEP) and reducing (10
mM TCEP) environment when incubated for 4 h (Figures 4.8, 4.9). 72 h (Figures 4.10,
4.11) and 7 days (Figures 4.12, 4.13). After 4 h of incubation, all the aggregate forms
were amorphous. Morphology of the aggregates changed after 72 h incubation and they
were similar to those observed after 7 days. In the absence of TCEP at physiological
temperature, insulin formed rod-like structures at acidic pH (Figure 4.12 A, B) and
amorphous aggregates at pH 8.8 (Figure 4.12 C). At neutral pH (Figure 10 D), no
aggregation is observed. At elevated temperature, fibrillation is observed at pH 2.0 and
5.3 (Figure 4.12 E, F), however fibril morphology is different at both pH. At neutral
pH (Figure 4.10 G), aggregates formed are amorphous in nature whereas sponge-like
amorphous aggregates are observed at basic pH (Figure 4.12 H). In the presence of 10
mM TCEP, amorphous aggregates were observed at pH 2.0, 37 oC and at neutral pH
for both incubation temperatures (Figure 4.13 A, C, G). However at 65 oC the
aggregates were amorphous at pH 2.0 (Figure 4.13 E). At pH 5.3 and 8.8 insulin formed
short, branched and long filaments, respectively at both physiological and elevated
incubation temperatures (Figure 4.13 B, F, D, H). The stark difference in 4 h aggregates
versus the later time points is also conspicuous from the ANS and Bis-ANS
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fluorescence data. Increase in fluorescence (ANS, Bis-ANS) for the first 4 h of
incubation suggests that these amorphous aggregates are transient and flexible that is
formed by exposing the hydrophobic pockets. Gradual decrease of ANS, Bis-ANS
fluorescence (Figures 4.2, 4.3) beyond 4 h, signifies reorientation and formation of
stable, less flexible structures by hydrophobic collapse and burial. These observations
also support earlier studies that amorphous aggregates convert into fibrils at low pH,
high temperature and oxidizing environment.
Insulin is known to form fibrils at low pH and high temperature. Previous studies have
shown that long-term incubation of insulin converts amorphous aggregates in fibrils.
In order to compare the effect of incubation temperature towards fibril formation,
insulin was incubated for 4 weeks at 37 and 65 oC in the presence and absence of 10
mM TCEP. The aggregates were characterized using ThT fluorescence and electron
microscopy (Figure 4.14). Under reducing conditions at pH 2.0, insulin converted to
filaments at 37 oC, and aggregate morphology did not change for 65 oC incubation
temperature (Figures 4.14A – c, d). ThT fluorescence intensity for aggregates formed
at both temperatures is comparable (Figure 4.14A). In the absence of TCEP, the rodlike filamentous structures converted to fibrils at 37 oC with a significantly high ThT
fluorescence. Fibrils formed at 65 oC in 7-days converted into tightly wound fibrils
after 4 weeks of incubation with ThT fluorescence intensity about ¼ to the fibrils at
formed at physiological incubation temperature (Figures 4.14A – a, b). This can be
explained in light of the structural differences between the fibrils formed at both
temperatures. Fibrils formed after 4-weeks at 37 oC are loosely wound hence allowing
space for ThT molecules to bind tightly and fluoresce. At 65 oC, the fibrils are tight and
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twisted with minimal cavity for binding of ThT leading to low fluorescence and
quantum yield. Kayed and coworkers observed thioflavin S negative results in human
Alzheimer’s disease brain although it was fibril-positive using antibodies, confirming
that thioflavin class of dye requires a specific binding cavity into the fibril in order to
fluoresce 57. Our finding contradicts the evidence in literature that insulin forms fibrils
at elevated temperature and low pH since we observed tight fibrils at 37 oC after 4
weeks of incubation. This suggests that high temperature helps in accelerating the fibril
formation and also affects the fibril packing and corresponding ThT fluorescence
signal.
In case of pH 5.3, 7.0 and 8.8, aggregate forms did not change significantly and are
comparable to those observed after 7 days of incubation (Figures 4.12, 4.13). ThT
fluorescence intensity increased significantly in case of samples incubated with and
without 10 mM TCEP for at pH 5.3 (65 oC) (Figure 4.13 B) whereas fluorescence was
maximum in case of reduced insulin for both pH 7.0 and 8.8 at 65 oC and 37 oC
respectively (Figures 4.13 C, D). This suggests that ThT fluorescence is independent
of aggregate morphology and largely depends on the size and nature of grooves
available in the aggregate for ThT binding. Short filamentous and branched structures
do not bind to ThT molecule leading to lower fluorescence intensity as observed in case
of insulin aggregates without TCEP at pH 5.3. Similar trend is observed in case of pH
8.8. In the absence of TCEP the aggregates are filamentous however, the larger
amorphous aggregates contribute to maximum fluorescence intensity.
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Insulin forms diverse aggregate forms when incubated at various pH and temperatures
under reducing and non-reducing conditions. It is important to correlate aggregate
morphology with its cytotoxicity in order to understand the stresses (pH, temperature,
reducing agent) that contribute towards toxic aggregate formation. Insulin aggregates
were formed by incubating the protein for 7 days at pH 2.0, 5.3, 7.0 and 8.8 at 37 and
65 oC in the absence and presence of 10 mM TCEP. SH-SY5Y cells were incubated
with insulin aggregates for 48 h and the toxicity of the aggregates were assessed using
MTS assay. Aggregates formed due to scrambling of disulfide bonds at acidic pH, in
the presence of reducing agent were significantly more cytotoxic compared to the
aggregates with intact disulfide bonds. Reduction of disulfide bonds and possible
formation of non-native disulfide bonds is the driving force towards aggregation in the
presence of reducing agent. Scrambled disulfide bonds leads to instability of the
protein, which could be a critical factor apart from the pH. Toxic behavior was majorly
independent of incubation temperature. Maximum toxicity was observed for aggregates
formed at pH 2 (loose amorphous aggregates) followed by pH 5.3 (short filamentous
aggregates). This suggests that larger amorphous aggregates can be more toxic to cells
since they can sequester the proteins that are critical for maintaining homeostasis in
cells. Similar trend was observed in case of inclusion bodies in case of Huntingtin
protein aggregation 58. Longer fibrils/filaments and smaller amorphous aggregates (pH
8.8) are less cytotoxic when compared to shorter filaments since the latter can enter
cells owing to its small size and disrupt cellular functions. Insulin aggregates formed
at physiological and basic pH exhibited maximum cell viability compared to those at
acidic pH. This suggests the insulin aggregates at acidic pH, disrupt cellular function
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and confer toxicity in a multitude of ways, however reduced disulfide bonds add to the
toxic nature of the aggregates (Figure 4.16).

Figure 4.16 Plausible model of pH-dependent insulin aggregation and toxicity. Insulin
aggregates at pH 2.0 and 5.3 are relatively more toxic to SH-SY5Y cells, than those at
pH 7.0 and 8.8. Scrambling of disulfide bonds lead to increase in toxicity at acidic pH.
Cytotoxicity at neutral/basic pH is comparable for both oxidized and reduced forms of
the protein. Surface charge is shown on protein at respective pH using Adaptive
Poisson-Boltzmann Solver (ABPS) Software 59.
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Conclusion
In summary, this study monitors the kinetics and mechanism of insulin aggregation
under various external stresses in the form of pH, temperature and reducing
environment. Insulin aggregates in the presence of reducing agent within 4 h of
incubation at both physiological (37 oC) and elevated (65 oC) temperatures, at all pH
studied. In oxidizing environment, insulin aggregation kinetics and morphology is both
pH and temperature dependent. Morphology of insulin aggregates were diverse and
distinct ranging from amorphous, fibrils to filamentous structures. Aggregates formed
in the presence of reducing agent at acidic environment were more toxic to human
neuroblastoma (SH-SY5Y) cells compared to those formed in the absence of reducing
agent, suggesting that pH and disulfide bond status play an important role in toxicity
of the aggregated forms.
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Abstract
Misfolding and aggregation of proteins have been associated with various
neurodegenerative diseases. While we have intensely focused on understanding the
factors that govern misfolding and aggregation of proteins in vitro; not enough focus
has been devoted to understanding how molecular crowding may impact the process.
It is important to mimic the protein-misfolding scenario within the crowded cellular
environment. Therefore, we have used macromolecular crowding agent polyethylene
glycol (PEG) to mimic molecular crowding in cells.
The main aim of this study is to understand the effect of macromolecular crowding
agent PEG on lysozyme stability and aggregation in the presence of thermal and
reducing environment stress. We investigated lysozyme unfolding between 25-95 oC
using temperature dependent intrinsic and ANS fluorescence spectroscopy in the
presence of both thiol and non-thiol based reducing agents dithiothreitol (DTT) and
tris-(2-carboxyethyl) phosphine (TCEP). Varying concentrations of PEG-600 and
PEG-2000 were used as molecular crowding crowding agents. 200 mM of PEG-2000
exhibited stabilizing effect towards lysozyme in the presence of TCEP whereas PEG
had no effect in the presence of DTT, irrespective of the molecular weight used in the
study.
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Introduction
Protein misfolding and aggregation have been linked to several neurodegenerative
disorders and amyloid diseases1. Protein aggregates are majorly found as deposits
within the brain, liver, spleen and heart2. These aggregated forms have been generated
in many in vitro studies using both physiological and non-physiological conditions to
understand the mechanism of the disease process. These studies are carried out in dilute
environment, which is significantly different than the cellular environment. The interior
of all cells contains high concentration of macromolecules (proteins, polysaccharides,
lipids) that occupy approximately 30% of the cell volume. These macromolecules lead
to volume exclusion causing significant thermodynamic and kinetic consequences on
the properties of other molecules present in the cell3. Volume exclusion effect leads to
specific

and

non-specific

interactions

within

the

cell

leading

to

perturbations/alterations in the biochemical processes within the cell. Crowding is
known to favor formation of macromolecular complex and the compact conformations
of proteins as opposed to its unfolded state4. Hence, it is important to investigate the
mechanism of protein folding and aggregation in a crowded environment in order to
understand the disease process.
Lysozyme is a widely studied model protein due to its rich phase behavior that includes
crystallization, liquid-liquid phase separation and formation of equilibrium
clusters/gels5. The biophysical characteristics of this 14.7 kDa globular protein has
been extensively studied by measuring the average properties of the conformational
isomers that exist at thermodynamic equilibrium in denatured lysozyme6. Studies with
lysozyme have shown that high concentrations of crowding agent (200 g/L) did not
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affect refolding of oxidized lysozyme but disrupted the refolding of protein. Denatured
lysozyme with intact disulfide bonds can be renatured efficiently by rapid dilution
whereas renaturation of the reduced protein by dilution is inefficient unless the protein
concentration is significantly low. Two-state unfolding mechanism of lysozyme was
studied using disulfide-scrambled lysozyme7. However, very little is known how
molecular crowding agents impact lysozyme stability and aggregation in the presence
of disulfide reducing agents. The general mechanism of protein misfolding and
aggregation of disulfide reduced protein is by scrambling of disulfide bonds8, 9. Hence,
it is important to understand how crowding agents can impact protein aggregation
under reducing conditions. For this we used lysozyme as a model protein as its
aggregation properties in dilute solutions have been extensively studied6, 7.
A large number of molecules are known to provide volume exclusion effect in in vitro
studies10. At high concentrations, these molecules preferentially hydrate the protein
surface, thereby favoring the compact state of the protein11. These molecules include
amino acids, salts, sugars and polymers like polyethylene glycols (PEG). The
mechanism of action in case of most amino acids, sugar and salt is through cohesive
force of water that is known to stabilize the native structure of the protein. However,
PEG is known to exhibit both stabilizing and destabilizing effects on the protein12.
Multiple theories have been proposed to explain the mechanism of action of PEG on
protein13. Preferential hydration in the presence of the polymer has been hypothesized
to be due to steric exclusion as well as charge on the protein14. Steric exclusion arises
due to the difference in size of the water molecule and that of the additives/crowding
agents. The large size of crowding agents such as PEG is key in its exclusion from the
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protein surface by steric exclusion mechanism11. The effect of PEG on protein thermal
stability has been shown to be molecular weight and concentration dependent15.
However, how does PEG impact stability of disulfide reduced proteins has not been
studied.
The main aim of this study is to investigate the thermal unfolding of lysozyme in the
presence of PEG and disulfide reducing agents dithiothreitol (DTT) and tris (2carboxyethyl) phosphine (TCEP). DTT is a thiol based reducing agent unlike TCEP.
Thermal unfolding of lysozyme was monitored between 25 oC to 95 oC in the presence
of varying concentration of reducing agents and PEG in order to understand the effect
of concentration on thermal unfolding of lysozyme. Effect of molecular weight of PEG
on lysozyme unfolding was also studied using a low (600 g/mol) and medium (2000
g/mol) molecular weight of the polymer.

Materials and Methods
Unless otherwise indicated, all materials were used as supplied by the manufacturer
without any further purification. TCEP was purchased from Thermo Scientific Pierce;
lysozyme, DTT, 8-anilino-1-naphthalenesulfonic acid (ANS) dye, PEG-600 and PEG2000 were purchased from Sigma.
Preparation of Lysozyme Samples - Lysozyme stock was freshly prepared by
dissolving

the

lyophilized

protein

in

20

mM

4-(2

hydroxyethyl)-1-

piperazineethanesulfonic acid (HEPES) buffer at pH 7.0. Lysozyme concentration was
determined using UV-Visible spectroscopy using extinction coefficient ɛ280 nm = 38940

177

M-1 cm-1. Working protein solution contained 40 μM protein in 20 mM HEPES buffer
at pH 7.0.
Sample Preparation and Heat Treatments - Samples were prepared by incubating
lysozyme with varying concentrations of reducing agents DTT (2 and 5 mM) and TCEP
(0.5 and 1 mM), along with 20 and 200 mM of PEG-600 and PEG-2000. Respective
controls without PEG and reducing agents were also incubated.
For heat treatment, each sample was heated to a fixed temperature (25-95 oC, 5oC
intervals) for exactly 12.5 min and cooled on ice for 10 min16.
Intrinsic and extrinsic fluorescence spectroscopy - Fluorescence measurements were
carried out on a Horiba Jobin Yvon spectrofluorometer (Fluoromax-4) at room
temperature. Slit widths of 2 nm (entrance and exit) were used for all measurements.
After heat treatments, intrinsic fluorescence spectra of the samples were collected in
the 285-450 nm range after exciting at 280 nm.
For extrinsic fluorescence measurements, heat treated samples were incubated with 5
μM ANS dye for 15 min on ice. ANS stock solution was prepared in 100% ethanol.
Concentration of the dye was determined using extinction coefficient ɛ350 nm = 5000 M1

cm-1. Fluorescence spectra were collected between 400-650 nm after excitation at 380

nm.
Reducing and Non-Reducing Gel Electrophoresis - Heat treated protein samples
(40uM) at 50 oC and 95 oC were mixed with fresh prepared 100 mM iodoacetamide
(IAA) and incubated at room temperature for 2 hours to facilitate the blocking of free
thiol groups. The reaction was terminated by adding sodium dodecyl sulfate (SDS)
sample buffer containing no reducing agents and boiled for 3 minutes. The reduced
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protein samples were prepared by adding SDS sample buffer containing 5% βmercaptoethanol to protein samples (40uM) and was boiled for 3 minutes. All samples
(10 μg/lane) were run on 15% Tris-HCl polyacrylamide gel using Tris-glycine-SDS
buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3; Bio-Rad) for 3.5 hours at 80
V. The gels were stained using Coomassie blue stain and image was acquired using a
scanner.
Field-Emission Scanning Electron Microscopy (FESEM) - Samples were prepared as
described earlier. Briefly, heat treated samples were washed with MQ water and
aliquoted on SEM stubs and dried at room temperature. The samples were coated with
10 nm platinum using a sputter coater. Images were acquired using an acceleration
voltage of 10 kV.
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Results & Discussion
Lysozyme is a small globular protein with 4 disulfide bonds at positions C6-C127, C30C115, C64-C80 and C76-C9417. It is majorly α-helical protein with some β-sheet
structure and a loop. The disulfide bridge between C6-C127 connects the N- and Cterminal of the protein and is partially solvent accessible, whereas other disulfide bonds
are buried into the hydrophobic pocket of the protein. Under reducing conditions,
lysozyme unfolds leading to formation of a random-coiled polypeptide. The protein
exhibits two-stage thermal denaturation in the presence of chaotropic agents, thus
serving as a model protein for studying thermal unfolding and effect of macromolecular
crowding7. However, the denaturation process of lysozyme in the presence of reducing
agent and macromolecular crowding agent in combination with thermal stress is
unknown. Hence it is important to understand the unfolding of lysozyme with thermal
stress in the presence of both thiol and non-thiol based reducing agents DTT and TCEP
respectively. The mechanism of action of both reducing agents is distinct and it is
important to investigate their effect on lysozyme denaturation in a macromolecular
crowding environment18.
We monitored thermal unfolding of lysozyme between 25 to 95 oC in the presence of
20 and 200 mM of both PEG-600 and PEG-2000. Disulfide bond reduction of lysozyme
was carried out using varying concentrations of both thiol and non-thiol based reducing
agents DTT (2, 5 mM) and TCEP (0.5, 1 mM), respectively. Thermal unfolding of the
protein was monitored using intrinsic fluorescence spectroscopy (Figures 5.1, 5.2)14, 17.
Conformational change and hydrophobicity was measured using ANS fluorescence
(Figures 5.3, 5.4). Reducing gel electrophoresis (SDS-PAGE) was used to determine
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whether the protein was completely reduced due to the heat treatment (Figure 5.5).
Morphology of the aggregates in the presence of disulfide reducing agents and PEG
was monitored using scanning electron microscopy (FESEM) (Figure 5.6).
Lysozyme like other proteins, contain tryptophan residues that absorb UV radiation
and can be excited. The electronic transition back to the ground state is associated with
photon emission observed as intrinsic fluorescence. This signal quenched in aqueous
environment19. Unfolding of lysozyme due to thermal stress in the presence of TCEP
and DTT was monitored. In the absence of TCEP and DTT, intrinsic fluorescence is
not observed even in the absence and presence of 20 and 200 mM (Figures 5.1, 5.2). In
the presence of 0.5 and 1 mM TCEP, intrinsic fluorescence in observed in the presence
of PEG (Figure 5.1). Earlier studies have shown the tryptophan fluorescence of proteins
get affected in the presence of PEG. Fluorescence is not observed in case of native
proteins, which is in line with our observation of no fluorescence intensity in the
absence of TCEP. However, PEG is known to bind to the molten globule form of
proteins20. Presence of 0.5 and 1 mM TCEP can partially unfold lysozyme, leading to
the formation of molten globule structure, thus facilitating PEG binding with lysozyme
and hence increases fluorescence20. In the presence of 200 mM PEG-600 and PEG2000 fluorescence intensity decreases suggesting stabilization of the protein structure
by PEG binding. Previous studies have shown that PEG bound to protein can either be
stabilizing or destabilizing depending on the size of PEG10. We observe similar trend
where PEG-600 does not have any significant stabilizing effect whereas the higher
molecular weight form of PEG has a greater stabilizing effect on the protein.
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In the presence of both 2 and 5 mM DTT, intrinsic fluorescence is observed for both
PEG-600 and PEG-2000 (Figure 5.2). This suggests that the mechanism of disulfide
reduction plays an important role in the thermal unfolding of lysozyme. DTT reduced
disulfide bonds are known to oxidize with time and form non-native disulfide bridges,
whereas reduction of disulfide bonds is an irreversible process in the presence of nonthiol based reducing agent TCEP18. This is in line with an earlier study where authors
observed that thiol based reducing agent inhibited lysozyme refolding in the presence
of guanidine hydrochloride, whereas the oxidized form of the protein refolded.
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Figure 5.1. Effect of PEG on the thermal unfolding of lysozyme in the presence of
TCEP, monitored by intrinsic fluorescence spectroscopy. Fluorescence spectra of
thermal unfolding of 40 μM lysozyme from 25 oC to 95 oC was measured in the
presence of (A) 0.5 mM TCEP, PEG-600 (B) 0.5 mM TCEP, PEG-2000 (C) 1 mM
TCEP, PEG-600 and (D) 1 mM TCEP, PEG-2000. Samples were excited at 280 nm
and emission spectra were collected between 285-450 nm. Peak wavelength of 365 nm
was chosen based on the difference spectra.
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Figure 5.2. Effect of PEG on the thermal unfolding of lysozyme in the presence of
DTT, monitored by intrinsic fluorescence spectroscopy. Fluorescence spectra of
thermal unfolding of 40 μM lysozyme from 25 oC to 95 oC was measured in the
presence of (A) 2 mM DTT, PEG-600 (B) 2 mM DTT, PEG-2000 (C) 5 mM DTT,
PEG-600 and (D) 5 mM DTT, PEG-2000. Samples were excited at 280 nm and
emission spectra was collected between 285-450 nm. Peak wavelength of 365 nm was
chosen based on the difference spectra.

Exposure of hydrophobic pockets due to thermal unfolding of lysozyme was monitored
using ANS dye (Figures 5.3, 5.4). Presence of PEG-600 did not affect the
hydrophobicity of lysozyme when compared with samples with PEG and 0.5 mM
TCEP (Figure 5.3 A). However, 200 mM of PEG-2000, lead to decrease in ANS
fluorescence in the presence of 0.5 mM TCEP signifying decreased hydrophobicity.
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Significant decrease in hydrophobicity and consecutive ANS fluorescence was
observed in the presence of 1 mM TCEP and 200 mM PEG-2000 (Figure 5.3 C)
whereas subtle decrease in fluorescence was observed with PEG-600 and 1 mM TCEP
(Figure 5.3 D). Control groups without TCEP and increasing concentrations of PEG600 and PEG-2000 did not show any fluorescence due to lack of protein unfolding and
exposure of hydrophobic pockets. This is in line with the intrinsic fluorescence data
where significant lysozyme stabilization was observed in the presence of 1 mM TCEP
and 200 mM PEG-2000.
ANS fluorescence results with DTT are in line with intrinsic fluorescence and no
change is observed in the presence of PEG with 2 and 5 mM DTT.

185

Figure 5.3. Effect of PEG on the hydrophobicity of lysozyme in the presence of
TCEP, monitored by ANS fluorescence spectroscopy. Fluorescence spectra of
thermal unfolding of 40 μM lysozyme from 25 oC to 95 oC was measured in the
presence of (A) 0.5 mM TCEP, PEG-600 (B) 0.5 mM TCEP, PEG-2000 (C) 1 mM
TCEP, PEG-600 and (D) 1 mM TCEP, PEG-2000. Samples were excited at 380 nm
and emission spectra was collected between 400-650 nm. Peak wavelength of 365 nm
was chosen based on the difference spectra.
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Figure 5.4. Effect of PEG on the thermal unfolding of lysozyme in the presence of
DTT, monitored by ANS fluorescence spectroscopy. Fluorescence spectra of
thermal unfolding of 40 μM lysozyme from 25 oC to 95 oC was measured in the
presence of (A) 2 mM DTT, PEG-600 (B) 2 mM DTT, PEG-2000 (C) 5 mM DTT,
PEG-600 and (D) 5 mM DTT, PEG-2000. Samples were excited at 380 nm and
emission spectra were collected between 400-650 nm. Peak wavelength of 365 nm was
chosen based on the difference spectra.

Non-reducing SDS PAGE of heat-treated samples at 50 oC and 95 oC show formation
of dimeric species at 50 oC in the presence of 1 mM TCEP whereas at 95 oC, dimers
are visible in the presence of DTT only (Figure 5.5). This suggests the protective role
of 1 mM TCEP towards lysozyme aggregation as the protein unfolds due to increase in
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heat treatment temperature. In line with fluorescence study, lysozyme aggregates in the
presence of DTT and PEG does not affect the aggregation process.
Morphology of heat-treated lysozyme samples was visualized using scanning electron
microscope. Lysozyme samples that were exposed to 50 oC did not show any aggregate
formation under the microscope (data not shown). However, a higher molecular weight
(28 kDa) is visible in the non-reducing gel. This suggests the formation of lysozyme
dimer due to intermolecular interaction but not visible aggregates under the scanning
electron microscope. Samples heat-treated to 95 oC show amorphous aggregate
formation both in the presence of TCEP and DTT.

Figure 5.5. SDS Gel Electrophoresis of heat-treated lysozyme samples. Lysozyme
(10 μg/lane) was loaded on 15% gel. The gels were run for 3.5 hours at 80 V followed
by staining with Coomassie blue stain. Reducing SDS-PAGE was run for heated treated
lysozyme at (A) 50 oC and (B) 95 oC. Samples were reduced using 5% βmercaptoethanol and boiled for 3 minutes. High molecular weight species were
visualized using non-reducing SDS-PAGE for heat-treated lysozyme at (C) 50 oC and
(D) 95 oC, after blocking the free sulfhydryl groups with 100 mM iodoacetamide.
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Figure 5.6. Scanning electron micrographs of lysozyme aggregates. Heat-treated
lysozyme samples were imaged using SEM. Lysozyme was heat treated at 95 oC with
(A) 1 mM TCEP, 200 mM PEG-600 (B) 1 mM TCEP, 200 mM PEG-2000 (C) 2 mM
DTT, 200 mM PEG-600 (D) 2 mM DTT, 200 mM PEG-2000

Conclusion
In summary, the role of macromolecular crowding agent PEG in lysozyme unfolding
was investigated. The protein was exposed to a range of thermal stress between 25 to
95 oC, in the presence of thiol and non-thiol based reducing agents DTT and TCEP
respectively. In the presence of TCEP, lower concentrations of PEG-600 and PEG2000 (20 mM) did not have any effect on lysozyme, however 200 mM of PEG had a
stabilizing effect on the protein. Stabilization was monitored using temperaturedependent intrinsic and extrinsic fluorescence and it was directly related to the
molecular weight of the macromolecular crowding agent. Lysozyme in the presence of
DTT did not have any effect of PEG and aggregation of the protein was observed at
higher temperatures. This suggests that the mechanism of action of the reducing agent
plays an important role towards the efficacy of PEG in stabilizing the native structure
of lysozyme.
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Chapter 6. Conclusion and Future Directions
The broad aim of this work is to investigate the aggregation kinetics, mechanism and
morphology of model protein insulin, in the presence and absence of disulfide-reducing
agents and its relation to cellular toxicity. Elucidating protein aggregation mechanism
and its implications for cellular toxicity is important in order to understand
neurodegenerative disease process that are primarily due to protein misfolding.
The main aim of the first project was to investigate the aggregation kinetics and
mechanism of insulin in the presence of dithiothreitol (DTT) – a thiol based reducing
agent, using various spectroscopic techniques (Chapter 3). Morphology of the
aggregates were characterized using scanning electron microscope. Nucleation
dependent aggregation of insulin in the presence of preformed seeds were monitored
using fluorescence spectroscopy and atomic force microscopy. Insulin formed
amorphous aggregates in the absence of seeds whereas in the presence of seeds,
transient fibril formation was observed that converted to amorphous forms within 24
hours.
Based on the findings from the first project, subsequent work involved correlation of
insulin aggregates with their cytotoxicity using human neuroblastoma (SH-SY5Y) cells
(Chapter 4). Diverse forms of insulin aggregates were prepared in the presence and
absence of tris (2-carboxyethyl) phosphine (TCEP) – a non-thiol based reducing agent,
using a variety of pH and temperature conditions. Insulin aggregates were prepared at
acidic, neutral and basic pH at physiological (37 oC) and elevated (65 oC) temperature.
193

Cell viability in the presence of insulin aggregates with reduced disulfide bonds were
much lower compared to their oxidized counterpart suggesting the importance of
disulfide bonds in native protein fold.
The objective behind studying protein aggregation kinetics and its mechanism is to
identify factors that influence protein aggregation. The goal is to characterize these
distinct aggregate forms from the same protein under different condition and to identify
the toxic fold/shape.
As cellular environment is highly crowded we wanted to understand how these
destabilizing factors (disulfide reducing conditions, temperature) can influence protein
stability and aggregation. Macromolecular crowding agents have been known to
stabilize proteins against thermal stresses and against denaturants. The third part of the
work involves understanding the protective role of a crowding agent polyethylene
glycol (PEG) against lysozyme aggregation in the presence of thermal and reducing
stress (Chapter 5). The role of concentration and molecular weight of PEG towards
lysozyme aggregation at a range of temperature (25-95 oC) and reducing stress was
studied. PEG was found to prevent lysozyme aggregation in a molecular weight and
concentration dependent manner.
The mechanism of protein aggregation in neurodegenerative diseases has been shown
to be generic in nature. Hence, information obtained from study of model proteins can
be extrapolated to disease causing proteins such as TAR DNA binding protein (TDP43), Amyloid-beta protein (Aβ-42), Superoxide dismutase 1 (SOD1) etc.
Characterizing various aggregate forms of model proteins, and correlating these
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aggregates to their toxicity is important in order to understand neurodegenerative
disease process. However, the scarcity of information about the disease related proteins
increase the complexity. So, it will be important to study other model proteins and also
characterize disease related proteins under similar experimental conditions in order to
understand how protein misfolding and aggregation leads to these late onset
neurodegenerative diseases.
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